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Human embryonic stem cells (hESC) 
Human embryonic stem cells are mostly derived from the inner cell mass (ICM) of a 64-cell stage 
embryo, called a blastocyst. This blastocyst, consisting of trophectoderm (outer layer) and ICM, is 
generally derived by means of in vitro fertilization (IVF) and donated to science after informed consent 
(1). hESC arise from this ICM after different intermediate states (2).  
hESC distinguish themselves from other cells by two properties: (1) self-renewal and (2) pluripotency 
(1). This capability to self-renew is due to telomerase. This reverse transcriptase enzyme elongates the 
3’end of DNA strands in the telomere region by adding TTAGGG preventing chromosomal damage 
during DNA replication (3, 4). Pluripotency is the ability to differentiate to cells belonging to the three 
primary germ cell lines: endoderm (respiratory and gastrointestinal tracts), ectoderm (epidermis and 
nervous tissue) and mesoderm (muscle, bone, blood & cartilage) (4). Upon differentiation, stem cells 
start to display different grades of differentiation, making it possible to group them further (5, 6) (Figure 
1).  
 
Figure 1. Overview of the different grades of differentiation in stem cells.  
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These characteristics make hESC promising for use in different applications in the future: new medicines 
(toxicity screening), studies regarding embryogenesis and regenerative therapy (organ transplantations) 
(1). Although some results in the field of regenerative therapy are promising, for example the in vitro 
differentiation to cardiomyocytes (7), many challenges remain. In particular, the large amount of cells 
needed for differentiation and the problem of immunological rejection due to a different expression of 
major histocompatibility complex I (MHC I) antigens are major hurdles (8). A solution to the latter 
could be the generation of induced pluripotent stem cells (iPSC), as developed by Takahashi & 
Yamanaka (2006) (9). These cells are generated out of the patient’s own somatic cells avoiding the graft 
versus host problem. iPSC are made by transfecting the somatic cells with a vector system in which a 
virus contains the genes (OCT4, SOX2, KLF4 and c-MYC/n-MYC or OCT4, SOX2, LIN28 and NANOG) 
to obtain pluripotent cells (10). The efficiency of cellular programming can be enhanced by the use of 
small molecules for example vitamin C or valproic acid (11). While promising, generation of iPSC gives 
rise to alterations in the DNA (DNA methylation amongst others), resulting in a higher risk of tumor 
development (12, 13).  
1. Characterization of hESC  
1.1 Transcription factors and cell surface antigens 
The transcription factor OCT4 (encoded by OCT4 or synonyms POU5F1 and OCT3, class V of the POU 
family), discovered in 1991, is expressed in pluripotent stem cells (1). OCT4 can activate and inhibit a 
wide range of genes related to embryo development: OCT4 activates amongst others the genes Fgf4, 
Opn, Rex1 and Utf1 (14-16). In hESC, the levels (low or high) of OCT4 in combination with the possible 
activation of the bone morphogenetic protein 4 (BMP4) pathway regulates a different developmental 
state. High levels of OCT4 in the presence or absence of BMP4 promotes respectively mesendodermal 
differentiation and non-differentiation. Low levels of OCT4 in the presence or absence of BMP4 
promotes respectively extraembryonic lineage and primitive endoderm differentiation and ectoderm 
differentiation (17). Two other important pluripotency transcription factors are SRY-related high-
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mobility group box protein-2 (SOX2) and NANOG (called after Tir nan Og) (14, 18). In general, it is 
reported in hESC that a decrease in SOX2 and NANOG expression results in differentiation to cells 
positive for markers of primitive endoderm and trophectoderm (14, 17, 19). These genes can 
quantitatively be determined by means of real-time PCR and microarray platforms (20, 21). hESC 
differentiation on the other hand is characterized by increased expression of GATA4/GATA6 for 
endodermal differentiation and GATA2/CDX2 for trophectodermal differentiation, amongst others (14). 
In addition, cell surface antigens related to hESC pluripotency can be determined by immunostaining in 
combination with fluorescence microscopy or flow cytometry. Some examples are stage-specific 
embryonic antigen (SSEA-3 & SSEA-4) and keratan sulfate antigen (TRA-1-60 & TRA-1-81) (4, 22). 
Of note, high alkaline phosphatase levels are also a marker of undifferentiated hESC (23). 
1.2 Signaling pathways 
Four main pathways involved in pluripotency can be distinguished: (1) transforming growth factor β 
(TGFβ)-activin-NODAL pathway, (2) phosphatidylinositol 3-kinase (PI3K) pathway, (3) Ras-Raf-MEK 
(mitogen activated protein kinase kinase)-ERK (extracellular signal-regulated kinase) pathway or 
MAPK/ERK pathway and (4) the WNT pathway (14, 24-26) (Figure 2). Addition of activin A to a 
hESC culture activates the TGFβ-activin-NODAL pathway through the signal transducer SMAD2/3 
(24). Addition of fibroblast growth factor on the other hand activates the PI3K pathway and the Ras-
Raf-MEK-ERK pathway. In short, for the PI3K pathway, phosphatidylinositol 4,5-bisphosphate 
becomes phosphorylated by means of PI3K during activation. This phosphatidylinositol 3,4,5-
triphosphate binds with Akt (also known as protein kinase B). Activation of this pathway results in 
increased concentrations of OCT4, NANOG and SOX2 and consequently maintenance of pluripotency 
(26, 27). On the other hand, activation of Ras-Raf-MEK-ERK pathway leads to the activation of Ras (a 
GTPase), which in turn binds with Raf. This kinase phosphorylates another kinase, MEK, which 
phosphorylates ERK. ERK translocates to the nucleus leading to the phosphorylation of c-Myc, c-Jun 
and c-Fos (28, 29). The WNT signaling pathway is activated by 6-brominedirubin-3’-oxime (BIO). This 
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agent inhibits glycogensynthase kinase-3 which normally promotes the degradation of β-catenin in a 
complex with Axin and APC (adenomatous polyposis coli protein) by making it a target for the 
proteasome (29, 30). As a consequence, β-catenin accumulates in the cytoplasm and a portion of this 
pool translocates to the cell nucleus and interacts with genes important for keeping hESC 
undifferentiated (25). 
 
Figure 2. Signaling pathways regulating pluripotency. (Image taken from (31)) 
Some important differences exist between mouse and human embryonic stem cells. While the leukemia 
inhibitory factor (LIF)-STAT3 pathway is required for maintaining a pluripotent state only in mouse 
embryonic stem cells, BMP4 causes differentiation to trophoblast only in hESC (through the signal 
transducer SMAD1/5/8) (14, 32). This is in contrast to mouse embryonic stem cells, in which the 
combination BMP4 with LIF helps in maintaining the pluripotent state by suppressing the neural 
differentiation (14, 32).  
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1.3 Karyotype 
hESC need to be karyotyped because of genomic alterations (gain of chromosomes 12 and 17) that arise 
during culture. Karyotypical changes can have an impact on self-renewal and proliferation (33). The 
detection of chromosomal aberrations is routinely performed by Giemsa banding (G-banding) (33). 
Newer techniques are spectral karyotyping or multicolor-fluorescence in situ hybridization and digital 
karyotyping (34, 35). In spectral karyotyping, the chromosomes are visualized using fluorescence. This 
fluorescence is obtained by using fluorophore labeled single-stranded DNA (= probe) specific for a 
region of a chromosome. After hybridization with the chromosome, spectral differences can be 
observed. The main advantage in comparison with G banding is that no specialized training is needed 
to observe the differences in a chromosome (34). Digital karyotyping (Single Nucleotide Polymorphism 
arrays or array comparative genome hybridization) is a quantitative-based analysis of short sequences 
of DNA. In this method, DNA sequences specific for a region on the chromosome are used on a 
microarray plate. In short, DNA of the sample and of the control are labeled with a different fluorophore. 
After hybridization on a microarray plate, analysis can be obtained. A disadvantage of this technique is 
that it cannot be used to detect aberrations that do not result in copy number changes (for example 
inversion) (35, 36). 
Additionally, epigenetic changes (DNA methylation-histone tail modifications) arise, but these are not 
as of yet routinely characterized. 
2. Culture of hESC 
Thomson et al. (1998) were the first to culture hESC on mouse embryonic fibroblasts (MEF) with hESC 
medium (4). This culture method, named feeder culture, uses replication deficient fibroblasts (treated 
with mitomycin C/γ-irradiation) for hESC attachment (coating) (4). Attachment is possible because of 
the expression of different extra-cellular matrix proteins (ECM) at the cellular membrane of the 
fibroblasts. A few examples are the expression of collagen IV and laminin (37). It is believed that the 
main interaction between ECM and hESC is due to the binding to specific integrines (for example α6β1) 
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present at the cell surface of hESC (8, 38). Besides attachment, these cells are also producing factors 
needed to keep hESC undifferentiated and are for this reason called feeder cells. 
Feeder cell culture of hESC comes with several difficulties: high work load because of the culture of 
feeder cells, lot-variability, undefined culture and the use of animal products that would result in 
immunological rejections and risk on zoonosis, viruses and prions when later applied in the clinic (1, 
39). For this reason, the search for new feeder-free culture models was explored. A feeder-free culture 
combines a coating for hESC attachment and a specific medium which contains pluripotency promoting 
factors (37). One of the first coatings available was Matrigel®. Matrigel® is a combination of different 
ECM proteins (laminin, collagen IV, entactin and heparan sulphate proteoglycan) extracted out of 
Engelbreth-Holm-Swarm mouse sarcoma cells (1). Although successful in hESC attachment, Matrigel® 
has different disadvantages such as animal derived, lot-variability and undefined composition. Other 
defined coatings were thus developed: vitronectin, collagen IV, fibronectin and laminin. The potential 
of each coating to keep hESC pluripotent depends on the hESC medium it is combined with. The first 
hESC medium used was conditioned medium (CM) from fibroblasts (mostly derived from MEF called 
MEF CM). MEF CM is produced by incubating inactivated MEF for 24 hours in hESC medium 
consisting out of 80 % Knockout-Dulbecco’s modified Eagle’s medium, 20 % KnockOut Serum 
Replacement (KO-SR), 1 mM L-glutamine, 0.1 mM β-mercaptoethanol, 1 % non-essential amino acids 
(NEAA), and 4 ng/ml human basic fibroblast growth factor. In combination with Matrigel® or laminin, 
hESC were kept pluripotent for at least 130 population doublings in this way (8). MEF CM is however 
still undefined, lot-variable and of animal origin. Proteomic analysis of this medium to determine 
pluripotency promoting factors resulted in a list of proteins (37, 40). Chin et al. (2007) tested 6 growth 
factors identified in MEF CM to keep hESC undifferentiated, but unfortunately hESC were not viable 
after 3 passages (3, 40).  
Meanwhile, molecular studies broadened our knowledge on how pluripotency is maintained. Out of this 
knowledge, new specific culture conditions were developed. An overview of some hESC culture 
conditions can be found in Table 1. Although some of these culture conditions were indeed successful 
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in keeping hESC pluripotent, a disadvantage was the presence of undefined factors in the media 
(HESCO) or coatings (Matrigel®) (39, 41). In 2011, Chen et al. developed a fully defined, xeno-free 
and albumin-free hESC culture condition consisting of vitronectin (coating) in combination with 
Essential8 (E8) as medium. E8 medium contains the following components: Dulbecco’s modified 
Eagle’s medium/F12 (basal medium) with insulin (19.4 mg/L), fibroblast growth factor 2 (100 µg/L), 
L-ascorbic acid-2-phosphate magnesium (64 mg/L), sodium selenium (14 µg/L), transferrin (10.7 
mg/L), sodium bicarbonate (543 mg/L) and NODAL (100 µg/L) or transforming growth factor beta (2 
µg/L) (42). This culture system was further used in this thesis.  
hESC cultures need to be passaged every 3-5 days to expand and to avoid differentiation and cell 
overgrowth. Different dissociative solutions and methods are available to passage the cells. T’Joen et 
al. (2011) have compared 4 dissociative solutions (TrypLETM Express, Trypsin-EDTA, Cell 
Dissociation Buffer and Accutase) with manual and bead-based passaging techniques. The use of Cell 
Dissociation Buffer scored the best in colony amount, produces stable expanding hESC lines and hESC 
remained pluripotent (43). Although the full composition is company confidential, cell dissociation 
buffer contains ethylenediaminetetraacetic acid (EDTA) and is prepared in phosphate buffered saline 
(PBS) without calcium and magnesium (44). At our lab, a similar buffer is used (0.5 mM EDTA prepared 
in DulbeccoPBS) as dissociative solution, as recommended by Thermo Scientific.  
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Table 1. Overview of some hESC culture conditions. 
Coating Medium Number of passages Reference 
Matrigel mTeR1 >30 passages (45, 46) 
MEF-CM 88 passages (47) 
Laminine MEF-CM 10 passages (38, 48) 
Gelatine MEF-CM <1 passage (8) 
20 passages (49) 
Cellstart StemPro 30 passages (46) 
Fibronectine HESCO 8 passages (39) 
MEF-CM 24 passages (47) 
Vitronectin mTeSR1 30 passages (46) 
E8 medium 25 passages (42) 
 
In contrast to hESC, mESC have a different culture condition. As mentioned earlier, other pathways are 
necessary to maintain pluripotency and self-renewal in mESC. mESC can be kept in culture on 
inactivated mouse embryonic fibroblasts or gelatin-coated flasks in combination with LIF (activates 
LIF/STAT3) and serum as growth factors (50, 51). BMP4 can substitute for serum and a fully defined 
medium can be obtained in this way (50). Instead of LIF and BMP4, one can also add 2i to the culture 
medium. 2i is a combination of the small molecule inhibitors named glycogen synthase kinase 3 
(CHIR99021) and extracellular regulated kinase (PD0325901). CHIR99021 enhances embryonic stem 
cell growth capacity and viability, while PD0325901 inhibits the MAPK/ERK pathway, which is 
responsible for differentiation in mESC (52). This is therefore in contrast to hESC in which activation 
of the MAPK/ERK pathway by means of bFGF is needed for keeping hESC undifferentiated (27).  The 
addition of LIF to this 2i medium enhances cloning efficiency (50).  
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Of note, two kinds of pluripotent stem cells can be found in mouse: mESC and mouse epiblast stem 
cells (mEpiSC). The differences between both cells are summarized in Table 2 (53). As can be observed, 
a different pluripotent state exists between mESC and mEpiSC. This primed form reflects a more 
developed form of pluripotency because not all cells can be formed out of this pluripotent state. For 
example, Honda et al. (2013) showed that naïve rabbit induced pluripotent stem cells could differentiate 
towards oligodendrocytes unlike their primed ones (54). It is clear that naïve stem cells have some 
advantages above their primed ones (single cell clonogenicity and homogeneous cell population) and it 
seems that in some cases naïve stem cells are better for clinical applications. For example, Jang et al. 
(2014) observed that neural stem cells from naïve mESC are more similar to bona fide neural stem cells 
in comparison with mEpiSC (55). For this reason, the derivation of naïve embryonic stem cells can be 
of high interest for clinical approaches. mEpiSC could be converted to mESC by exposure to the 
LIF/STAT3 pathway and improved by expression of KLF4, KLF2, NANOG or c-MYC (56). In addition, 
the characteristics of hESC show that these cells resembles more the primed state of pluripotency. In 
analog to the conversion of mEpiSC, primed hESC can be converted to naïve hESC by using the same 
ectopic forced expression of these markers in combination with LIF and 2i. Of note, forskolin which 
induces KLF4 and KLF2 expression can be used to transiently substitute for the ectopic transgene 
expression (56). Other ways to form naïve human embryonic stem cells are for example (1) directly 
from preimplantation embryo’s using 2i and bFGF and (2) by conversion of existing primed hESC by 
preculture in the histone deacetylase inhibitors butyrate and suberoylanilide hydroxamic acid, followed 
by culture in 2i with bFGF (57).  
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Table 2 Overview mESC versus mEpiSC. Differences between some of the characteristics between mESC and mEpiSC are 
presented.  
 mESC mEpiSC 
Pluripotent state Naïve Primed 
Morphology Domed  Flattened 
Corresponding in vivo tissue Early epiblast (pre-implantation) Epiblast (peri-/post-implantation) 
Single Cell clonogenicity  Yes No (trypsin intolerant) 
Cell population Homogeneous Heterogeneous 
Chimerism  High efficiency Very low efficiency 
Female X inactivation XaXa XaXi 
Genes expressed OCT4, NANOG, SOX2, KLF2, KLF4, 
KLF5, ZPF42, DPPA3, FGF4 
OCT4, NANOG, SOX2, DMNT3B, 
FGF5, MEIS1, SOX11 
Global DNA methylation Hypomethylated Hypermethylated 
Techniques used in hESC analysis 
In this dissertation, some techniques that can be used in culturing and studying hESC were refined. More 
specifically the daily monitoring of the pluripotency of hESC by measurement of the expression of 
OCT4 and the use of mass spectrometry to analyze the hESC proteome. More in particular, the sample 
preparation for label-free quantitation and Stable Isotopic Labeling by Amino acids in Cell culture 
(SILAC) for protein quantification was optimized.  
1. Daily screening technique for hESC pluripotency 
As described above, hESC can be monitored by either the expression of genes specific for pluripotency 
(OCT4, NANOG, SOX2) or for differentiation (SSEA-1) (18). Different techniques (real-time PCR, 
immunostaining, flow cytometry) can be used to that end, but have the disadvantage that the same cells 
cannot be kept in culture afterwards (destructive techniques).  
In this dissertation, a screening method was developed for daily monitoring of pluripotency (Chapter 
3) with continuous hESC culture. This screening method includes the use of a commercially available 
WA01 OCT4-enhanced green fluorescent protein (eGFP) Knock-In hESC line (Wicell Research 
Institute, Madison, WI, USA) coupled to fluorescence microscopy.  
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eGFP is an auto-fluorescent protein which absorbs light at 489 nm and emits at higher wavelength (509 
nm) (Stokes shift) (58, 59). This fluorescence can be measured with fluorescence microscopy (60). 
In this case, eGFP is used as a reporter molecule to monitor gene expression. The eGFP-coding sequence 
is placed under the transcriptional control of the promotor of OCT4, marker of pluripotency, giving a 
directly visible readout of the gene’s expression in a hESC culture. High eGFP intensity means high 
OCT4 expression, indicating pluripotency. This reporter hESC line was developed by Zwaka & 
Thomson (2003) by means of homologous recombination (Figure 3) (61). In short, a targeting vector 
(Figure 3A) is constructed by insertion of an internal ribosomal entry site (IRES)-eGFP and an IRES-
neomycine resistence gene (neo) into the 3’ untranslated region of the fifth exon of the human POU5F1 
gene (encoding OCT4). This cassette is flanked with 2 homologous arms. After electroporation, both 
neomycine resistance and flow cytometry to detect eGFP expression was used to detect cells which 
contain the construct (Figure 3B). Afterwards, differentiation was induced by growing hESC on 
Matrigel® with unconditioned medium. This validation of the reporter hESC line was examined with 
flow cytometry in which a loss of eGFP expression was observed after 5 days of differentiation (Figure 
3C).  
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Figure 3. Targeting of an IRES-eGFP-IRES-neo cassette into the 3’UTR of the gene OCT4. IRES = internal ribosomal 
entry site, eGFP = enhanced green fluorescent protein, neo = neomycine resistence gene, UTR = untranslated region (A) 
Partial structure of the human OCT4 (=POU5F1) gene and the gene-targeting vector. E, exon (B) Fluorescence microscopy 
(right) and phase-contrast microscopy (left) of OCT4 knock-in and wild type colonies. Bar, 25µm. (C) Flow cytometry of 
OCT4 knock-in undifferentiated (EGPF-positive) hESC (blue) and their differentiated form after 5 days of differentiation 
(red). (Image taken from (61))  
Flow cytometry is a laser-based technology that can be used for cell analysis (cell counting, analysis of 
specific markers by means of fluorescence, cell characteristics (size and internal cellular complexity). It 
is important that cells are passed through the laser beam one at a time to avoid incorrect results. This is 
obtained by hydrodynamic focusing in which the sheath fluid draws the sample fluid into the stream 
passing a small aperture. The laser beam falls subsequently onto the cell and the light will be scattered. 
The forward scatter gives information about the size of the cell, while side scatter (light detected 90 ° 
relative to the laser beam) gives information about the granularity or complexity of the cell. Cells of 
interest can be selected in the 2D scatter plot by gating of the population. Fluorescence of eGFP can 
simultaneously be measured by the detector (Figure 4) (62). Of note, cells need to be in suspension in 
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an isotonic solution. hESC, which grow in colonies, are as a consequence treated with 0.25 % trypsin-
EDTA to obtain single cells and suspended in PBS before analysis occurs. 
 
Figure 4. Flow Cytometry. Cells in suspension are focused to pass one by one through the laser by means of hydrodynamic 
focusing. The light that falls onto the cell is scattered. Forward scatter and side scatter of the light gives information of 
respectively size and complexity of the cell. By means of staining of a cell or by using a reporter cell line, fluorescence 
emitted by these cells can also be measured. (Image taken from (63)  
Of note, other reporter stem cell lines are also available (hESC lines containing a hREX-GFP construct 
or NANOG-eGFP construct) (64, 65). 
2. hESC and Proteomics 
Proteomics determines the gene and cellular function, directly at the protein level (66). The first 
proteomic dataset of undifferentiated hESC was provided in 2006 (67). Several of these proteins could 
be hypothesized to characterize stemness-specific proteins such as hepatoma-derived factor and cellular 
retinoic acid-binding protein 1. During time, a lot of proteomic analysis on hESC was performed in 
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which for example OCT4 and alkaline phosphatase were identified in pluripotent hESC (6). Proteomics 
is thus a valuable tool to study the biology of hESC and to enlarge our knowledge about these cells.  
When complete analysis of the proteome of cells is required, mass-spectrometry is currently the method 
of choice.  
A mass-spectrometer is built out of (1) an ionization source, (2) a mass analyzer (measures the mass-to-
charge (m/z) ratio of the ionized analytes) and (3) a detector (66). In this thesis two electrospray 
ionization-quadrupole-Time of Flight (ESI-Q-TOF) mass spectrometers were used: TripleTOF 5600 
(Sciex; (68)) and Synapt G2Si (Waters, (69)) (Figure 5). Of note, other mass spectrometers are 
commercially available and more information can be found about some of these mass spectrometers in 
the following article (70).  
 
An ESI-Q-TOF mass spectrometer uses ESI as ionization source and quadrupole and time-of-flight as 
mass analyzers. ESI, rather than Matrix Assisted Laser Desorption Ionization (MALDI) is mostly used 
as ionization source in shotgun approaches, because ESI can be coupled to liquid chromatography (LC), 
which is needed for the separation of the complex peptide mixture (66). A quadrupole is built out of 
four cylindrical rods in which a specific mass to charge ratio (m/z) can be selected by means of an 
electric field that is applied to the rods. In this way, a quadrupole can work as an ion guide (no selection 
of specific m/z, regulating ion in-flux), a filter (selection of specific m/z) and as a collision cell 
(fragmenting the peptide precursor ions by means of a collision gas). In the Synapt G2Si, the quadrupole 
technology is supplemented by Traveling Wave Technology (T-wave) which makes it possible to 
perform ion-mobility separation (IMS) (70). This ion-mobility is used as an extra separation step, which 
separates peaks according to their collisional cross section specified by the charge, size and shape of the 
peptide (71). Peptide ions with higher charge states experience a higher electric field resulting in a higher 
drift velocity resulting in a lower drift time. Finally, a time-of-flight makes use of the fact that each ion 
has its own kinetic energy depending on its m/z value (low-mass peptides reach the detector earlier) and 
determines in this way the ion’s m/z.  
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Figure 5. Representation of the mass spectrometers available in the Laboratory of Pharmaceutical Biotechnology: 
TripleTOF 5600 ( Sciex) and Synapt G2Si (Waters). 
Several approaches exist to analyze proteins. Complete proteins can be analyzed in top-down 
approaches, as opposed to analysis of peptides by bottom-up approaches or larger peptide sequences as 
is done in middle-down proteomics (72). In this thesis, a bottom-up approach (or shotgun approach) was 
used to analyze a complex proteomic sample. A bottom-up experiment can in general be described in 3 
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steps: (1) sample preparation (proteins → peptides), (2) LC-tandem mass spectrometry analysis (LC-
MS/MS) and (3) data analysis.  
In the next paragraph, the several steps of a bottom-up experiment are described in more detail.  
2.1 Bottom-up experiment  
2.1.1 Sample preparation  
The first step of a proteomics experiment can be cell lysis. Different surfactants and physical techniques 
(sonication, freeze-thaw) are available to lyse cells (73). The choice of surfactant will depend on the 
goal of the experiment: analysis of a complete cell proteome asks for an ionic detergent which breaks 
protein-protein interactions (for example sodium dodecyl sulphate (SDS)), while analysis of protein 
interactions requires a mild non-ionic detergent like Triton X-100, which keeps the protein-protein 
interactions intact (74). When cells are lysed, nucleic acids and proteases are released. An endonuclease 
(e.g. benzonase) is added to the cell lysis buffer to hydrolyze these nucleic acids, allowing a reduction 
of viscosity and improvement of the analysis of transcription factors. Proteins are protected against 
degradation by the addition of several protease (serine and cysteine proteases) and phosphatase 
inhibitors (serine and threonine phosphatases). This addition is especially essential when analyzing post-
translational modifications (72, 73).  
After lysis, proteins are either (1) directly cleaved into peptides (in-solution digest) or (2) fractioned e.g. 
by their molecular weight or isoelectric point, or by specific characteristics such as the presence of 
certain post-translational modifications (75). Fractionation is performed if the sample is too complex or 
if only a certain protein group (e.g. histones) is of interest. Two dimensional polyacrylamide gel 
electrophoresis (2D-PAGE) is a popular method to fractionate proteins.  
After fractionation (if needed) and protein quantitation, proteins are cleaved into peptides by digestion. 
For an optimal enzyme digest, the protein sequence has to be accessible to the digesting enzyme. The 
protein must therefore be (1) denatured and (2) disulphide bridges between cysteines need to be broken. 
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Several denaturants are nowadays available for complete denaturation, each with its own disadvantages 
(Table 3). As can be seen in Table 3, denaturants can have an inhibitory effect on the activity of the 
digesting enzyme (in this case trypsin). This inhibition is monitored by means of the formation of the 
UV active Nα-benzoyl-L-arginine (BA), the digestion product of BA ethyl ester (76). LC-MS/MS 
compatibility also needs to be considered. SDS for example can bind to the reverse phase column and 
acts as an ion-exchanger. In addition, SDS causes ion suppression resulting in non-ionized peptides 
which cannot be analyzed (77, 78). Finally, addition of a denaturant can induce modifications. Urea 
degrades to cyanate under high temperature, causing carbamylation of free amines (79). This 
modification has to be taken into account during data analysis. In this dissertation, the use of sodium 
deoxycholate (SDC) during cell lysis and in-solution digest was optimized (Chapter 4). 
 Subsequently, disulphide bridges present on cysteine-containing proteins are broken by first reducing 
the sample, most frequently by means of 10 mM dithiotreitol (DTT) or 5 mM tris(2-
carboxyethyl)phosphine) (TCEP). After reduction, the sample is alkylated to prevent the reformation of 
disulphide bridges. This is performed most often by the addition of 10 mM methyl methanethiosulfonate 
(MMTS) or 20 mM iodoacetamide (IAM). Of note, IAM can generate non-specific N and O-alkylation 
(80). 
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Table 3. Overview of some of the most used denaturants during digestion. SDS = sodium dodecyl sulphate; SDC = 
sodium deoxycholate. The effect on trypsin activity, compatibility with LC-MS/MS and peptide modifications of each 
denaturant is mentioned. 
Denaturant 
 
% trypsin activity 
(BA absorbance) 
Compatibility  
LC-MS/MS 
Inducing additional 
modifications 
Reference 
0.1 %/0.5 % Rapigest 100 %/87 % Removal necessary 
(acid) 
No (81-83) 
0.2 % ProteaseMAX 100 % Yes (degradable by 
trypsin) 
No (81) 
1 M/2 M Urea 97 %/83 % Yes Carbamylation of lysine 
and N termini (high °C) 
(82) 
0.1 %/0.5 % SDS 20 %/1 % Ion suppression No (76) 
1 %/2 % SDC 95.4 %/86.4 % Removal necessary 
(acid) 
No (76) 
 
Finally, the protease for digestion needs to be chosen. An overview of the different enzymes is shown 
in Table 4. Trypsin cleaves C-terminal to arginine and lysine, making that every peptide is at least 2+ 
(3+ charge is due to histidine in the sequence (84)). In this way, the peptide is easily ionized and trypsin 
is for this reason the most used protease. Of note, more protein identification could be obtained when 
the same sample is digested with more enzymes for example the combination of trypsin and GluC (72).  
In addition, sample clean-up is sometimes necessary: high salt concentrations can interfere with the 
ionization process of ESI, making sample clean-up with for example C18 ZipTips mandatory in some 
cases (85). Another issue is the presence of contaminants or impurities in the sample. These 
contaminants can be observed in the mass spectrum and are for example polyethylene glycol (PEG) or 
protein-related contaminants (e.g. keratins). Polyethylene glycol, a polymer built out of repeating units 
of (-CH2-CH2-O-), is present in some detergents (e.g. Triton X) or protease inhibitor cocktail tablets. 
This polymer leads to ion suppression of the sample during ESI and can be observed in the mass 
spectrum by a repeating train of peaks of 44 Da. Keratins, originating from clothing and human skin, 
are often present in the background. These proteins can be avoided by working with latex-free gloves in 
a laminar air flow closet (86, 87). 
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Table 4. Common Proteases Used for Shotgun Proteomics. (Image taken from (72)) 
Protease Cleavage specificitya Common proteomic usage 
Trypsin -K,R-↑-Z- not -K,R-↑-P-  General protein digestion 
Endoproteinase Lys-C -K-↑-Z- Alternative to trypsin for increased 
peptide length; multiple protease 
digestion 
Chymotrypsin -W,F,Y-↑-Z and –L,M,A,D,E-↑-Z- at a 
slower rate 
Multiple protease digestion 
Subtilisin broad specificity to native and 
denatured proteins 
Multiple protease digestion 
Elastase -B-↑-Z- Multiple protease digestion 
Endoproteinase Lys-N -Z-↑-K- Increase peptide length; create higher 
charge state for electron transfer 
dissociation (ETD, 2.1.2.) 
Endoproteinase Glu-C -E-↑-Z- and 3000 times slower at –D-
↑-Z- 
Multiple protease digestion 
Endoproteinase Arg-C -R-↑-Z- Multiple protease digestion 
Endoproteinase Asp-N -Z-↑-D- and Z-↑-cystic acid-but not –
Z-↑-C- 
Multiple protease digestion 
Proteinase K -X-↑-Y- Nonspecific digestion of membrane-
bound proteins 
OmpT -K,R-↑-K,R- Increase peptide length for middle-
down proteomics 
a B = uncharged, nonaromatic amino acids (i.e, A,V, L, I, G, S); X = aliphatic, aromatic, or hydrophobic amino acids; and 
Z = any amino acid. 
 
2.1.2 Liquid chromatography-tandem mass spectrometry analysis (LC-MS/MS)  
A cell lysate digest is too complex to analyze it with mass spectrometry alone. Therefore, peptides can 
be separated by using several techniques such as high performance liquid chromatography (HPLC). One 
of the most used methods is a HPLC system with a reverse C18 column as stationary phase (RP). By 
using a gradient with increasing organic content through time (=mobile phase), peptides are separated 
based on their hydrophobic, ionic and polar interactions with the stationary and mobile phase (88). A 
higher separation grade of a cell lysate, and thus reduced sample complexity, is possible with two-
dimensional liquid chromatography (2D-LC) (84). Peptides are in this technique separated in “two 
dimensions” based on two of their physical properties. Gilar and al. (2005) investigated a selectivity of 
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common LC modes and identified systems with useful orthogonality. Suitable orthogonality was 
observed by the combination of Strong Cation Exchange (SCX)-RP, hydrophilic interaction 
chromatography (HILIC)-RP and high pH – low pH RP-RP (84). Such an approach to reduce sample 
complexity is called multidimensional protein identification technology (MudPit) (89). Another 
approach is the isolation of a set of representative peptides. Only these peptides are analyzed to attain 
reduced sample complexity and increased proteome coverage. An example of this approach is 
COmbined FRActional DIagonal Chromatography (COFRADIC), which can be applied to isolate 
methionyl peptides and cysteinyl peptides, amongst others. In this technique, the sample is first 
chromatographically separated into fractions. Secondly, the sample is chemically or enzymatically 
modified on peptides containing rare amino acids, resulting in a hydrophilic or hydrophobic shift of the 
representative peptides. Some of the primary fractions are pooled and acquired. During the second run, 
the modified peptides have a shift in retention time in comparison with the first run and these peptides 
are analyzed with mass spectrometry (90).  
After separation, the peptides are analyzed with mass spectrometry as described above.  
Two kinds of fragment spectrum acquisition modes are possible in mass spectrometry: data-dependent 
(DDA) and data-independent acquisition (DIA) (91, 92). In data-dependent acquisition (DDA) the mass 
spectrometer switches between MS (=survey scan) and MS/MS (=fragmentation scan) mode. An MS 
precursor will be selected for fragmentation when a predefined intensity is reached. Subsequently, the 
mass spectrometer switches into MS/MS mode in which the precursor ion will be fragmented using 
collision induced dissociation (CID). By using CID, fragmentation happens at the amide binding of a 
peptide, creating b and y-ions and allowing peptide identification. Of note, fragmentation can also occur 
with electron transfer dissociation (ETD). ETD creates c- and z-type ions and preserves most of the 
post-translational modifications (93). Several problems are reported using DDA (94-96) :  
(1) only a fraction of the eluting precursors gets selected, resulting in poor peptide identification 
repeatability. Michalski et al. (2011) showed by using a LTQ-Orbitrap Velos that out of a HeLa cell 
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lysate 16 % of all precursor peptide ions were targeted for MS/MS of which 58 % were identified with 
a false discovery rate of 1 %.  
(2) Instrumental scanning speed in MS/MS is too low, resulting in loss of information about the 
precursor peptide ions that are eluting at that time. In addition, this MS/MS scanning can interrupt the 
acquisition of the eluting precursor peptide ion at that moment and this leads to inaccurate and non-
reproducible quantitation using Area Under the Curve (AUC) quantitation (2.2.1.3.). 
(3) cofragmentation of 2 precursor ion peptide precursors in the same isolation window leads to a mixed 
MS/MS spectrum, resulting in poor identification. This can be solved by using ion mobility - as present 
in Synapt G2Si - which isolates the two precursor ion peptide precursors before fragmentation. 
 
DIA was developed as a solution to overcome DDA related problems by discarding precursor ion 
selection altogether. Two types of DIA, both available at our lab, are elevated MS (MSE, performed on 
the Synapt G2Si) and Sequential Window Acquisition of all THeoretical fragment ion spectra (SWATH, 
performed on the TripleTOF 5600) (92). In MSE, the mass spectrometer alternates between low- and 
high energy collision conditions without preselection of a precursor ion. Intact precursor ions are 
recorded in the low energy scan, while in the high energy scan all precursor ions are fragmented by 
applying a collision energy ramp. This method is also called “parallel fragmentation approach”. The 
main challenge with MSE lies in the analysis of the data. In MSE, the fragment is connected with its 
precursor ion with the similarity in retention time profile (Accurate Mass Retention Time alignment, 
AMRT). An iterative depletion process is used in which the annotated peptides and their fragments are 
subsequently removed out of the data before analysis continues. However, the retention time profile 
alone proved to be inadequate for accurate identification and quantification (92, 95). For this reason, 
high definition MSE (HDMSE) was developed. Herein, traveling wave ion mobility separation (IMS) 
was merged with the conventional ESI-Q-TOF design. IMS gives an additional dimension of separation, 
a mobility profile or drift time, to more reliably connect the fragment with its precursor (92). This type 
of acquisition mode can be run only on a Synapt G2S- or Vion-type of intrument (Waters). This HDMSE 
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was further optimized to ultradefinition MSE (UDMSE), in which ion mobility drift time-specific 
collision energy profiles are used instead of a collision energy ramp. This is represented in Figure 6A 
(97). By using drift time specific profiles instead of an aspecific ramp, Tenzer et al. increased the 
fragmentation efficiency considerably, resulting in increased peptide identification and proteome 
coverage (Figure 6B (number of proteins) and C (number of peptides) (97).  
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Figure 6. UDMSE compared to MSE and HDMSE. (A) Schematic of HDMSE with ramped collision energy and UDMSE 
with drift time-dependent collision energy profiles in the elevated energy scan. (B, C) Comparison of MSE, HDMSE and 
UDMSE. HeLa tryptic digest (200 ng) was analyzed in triplicates by MSE, HDMSE and UDMSE using 90-min gradients 
(UDMSE-L: 300 ng, 180 min). Proteins and peptides were identified searching against UniProtKB/Swiss-Prot reference 
proteome (UPSP) and international protein index (IPI) human databases (B) Proteins (FDR <1%; 2 peptides/protein) and (C) 
peptides (FDR < 1%; ≥6 amino acids). (Image taken from (97))  
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In contrast to MSE, SWATH acquisition is acquired on the TripleTOF-type instruments (Sciex). In this 
acquisition mode, identification of peptides is still done using DDA acquisition, resulting in a library of 
peptides and their respective retention times. In the subsequent quantitation runs, a m/z range (400-1200 
Da) is divided into a number of precursor isolation windows (also called swaths or bins, somewhere 
between 3 and 25 Da in size). The precursor ions selected by this window are fragmented (MS/MS) and 
data is collected. The mass spectrometer iterates through all windows, before reanalyzing from the start 
(Figure 7A). A full MS scan (without CID) is also acquired with SWATH to obtain precursor ion 
information. Quantitative information is obtained from MS/MS peak-extracted ion chromatograms of 
fragment ions of targeted proteins and peptides by the relative quantification of peak areas (Figure 7B). 
Figure 7. SWATH MS data-independent acquisition and targeted data analysis. (A) A m/z range (400 -1200 Da) is divided into precursor 
isolation windows of around 25 Da width (orange arrows). During the run, the mass spectrometer repeatedly acquires these windows. The 
cycle time is defined as the time required to return to the acquisition of the same precursor isolation window and is around 2.5 sec. The MS 
scan, before the beginning of each cycle, is presented as a grey full line. (B) a MS/MS spectrum of a peptide. An extracted ion chromatogram 
of the fragment ion trances can be plotted for a specific time and can be evaluated. In this case, the y5 fragment has not the same retention time 
as the other fragments and is not used. (Image adapted from (98) and information provided on the website of Sciex) 
This is in contrast to MSE, which obtains information at the MS level (98). Of note, a spectral library of 
the proteins in the sample is needed for peptide identification. A pre-run of several DDA acquisitions is 
sometimes needed if no online library is available (94). In addition, co-fragmentation of precursors is 
inevitable using a 25 Da width bin resulting in an average of 3.4 peptide precursors which are fragmented 
simultaneously resulting in complex MS/MS spectra (99). 
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2.1.3 Data analysis 
After LC-MS/MS, peptides need to be identified. One way to identify the peptides is by means of 
sequence database searching. This was performed with the search engine Mascot (Matrix Science) in 
this dissertation (100). In this technique, RAW data files, obtained by the mass spectrometer, are first 
converted to peak lists. Subsequently a parameter file (type of enzyme, expected peptide charge, 
modifications (fixed or variable), MS and MS/MS tolerance) is filled out and a database (SwissProt) is 
chosen. The database is in silico digested taking into account the predefined parameters. Finally, the 
experimental peak list (containing the masses of precursor ions as well as of peptide fragmentation ions) 
is compared with the generated peaklist of the in silico digested database (100, 101). A probability-
based ion score and accompanying “expectancy value” is provided for each peptide, reflecting the 
probability of this match being a random event. Of note, no peptide identification can occur if (1) the 
used database doesn’t contain the peptide, (2) there are unknown modifications and (3) if the mass 
tolerance window is too narrow. An error tolerant search can be used to find new modifications (102).  
If an MS/MS spectrum is not identified, other approaches such as de novo sequencing, sequence tag-
based approaches or spectral matching can be considered (101, 103).  
Validation of the annotation accuracy can be done by a decoy database search (104). A decoy database 
consists of randomized or reversed sequences, so no true matches can be expected. The number of 
matches that is found, is an estimation of the number of false positives amongst the hits in the true 
database (104). The false discovery rate (FDR) can be calculated out of these data by dividing the 
number of matches in the decoy database (false positives) by the number of matches in the target 
database (true positives and false positives). A second way to validate the data is with the use of 
Percolator (105). Percolator is an algorithm which utilizes a semi-supervised machine learning for 
improved discrimination between correct and incorrect spectrum identifications. Data matches from a 
decoy search and high confident data are used as respectively incorrect and correct match examples 
(105). 
  
Introduction
 
  
 36 
MSE data can be analyzed with the commercially available Progenesis Q1 Software for Proteomics 
(Nonlinear Dynamics, Waters). This software works as is presented in Figure 8: first, retention time 
alignment is performed by aligning the retention time of all the samples to one sample, the quality 
control. This quality control (a mixture of all samples of the experiment) can equally be used to check 
the technical repeatability of the LC-Synapt G2Si, as it is run several times between the randomized 
samples. A score is given to each alignment. After alignment, peak detection is performed by Progenesis 
algorithm. Peak filtering is possible in which maximum charge (4+ in our case), minimum and maximum 
retention time, sensitivity and chromatographic peak width can be adapted. In parallel, a database search 
performed by the Ion Accounting algorithm has to be performed for peptide identification. An input file 
is generated by a combination of the Apex3D algorithm (peak detection), a lock-spray mass correction 
of the data and the Pep3D algorithm is used to group ions belonging to the same peptide. By means of 
AMRT, precursor ions are assigned to their product ions. A decoy database is generated using a protein 
FDR of 4 %. Next, the database search is performed by the Ion Accounting algorithm in which an 
iterative process is used. This iterative process consists out of three passes (99):  
(pass 1) Each parent/product ion list is matched against the protein database. The peptides are scored 
based on their correlation. The process terminates when the FDR is reached.  
(pass 2) Only the depleted data are used in this search. The peptides are subjected to possible 
modifications or non-specific cleavage and are assigned to peptides identified in pass 1.  
(pass 3) A product ion is allowed to have a higher intensity than its precursor ion (characterizing in-
source fragmentation). 
 
The output results file of the Ion Accounting algorithm is matched up against the Progenesis MS 
precursors at the end in the Identify Peptides stage of the workflow. Normalization can be performed. 
One can choose between “Normalize to all proteins” or “Normalize to a set of housekeeping proteins” 
such as a known amount of spike-in, for example Hi3 protein or β-galactosidase. Quantification can be 
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performed both relative and absolute (for example by means of the spike-in) based on the peak detection 
by Progenesis. In addition statistical analysis can be performed (106). 
 
 
 
 
 
 
 
 
 
 
  
 
2.2 Quantitative proteomics 
Besides identification of proteins, quantitative information concerning proteins is often mandatory for 
biological interpretation. Several MS-based techniques are available each of which contends with its 
own difficulties.  
First, one can chose between relative or absolute quantification. Relative quantification provides a 
protein ratio between two samples in which the ratio between abundances highlights the differences 
between two protein profiles. In absolute protein quantification, a protein quantity value is provided (for 
example “protein copies per cell”) making comparison across datasets possible. Another example of 
absolute protein quantification can be found in the field of new therapeutic and diagnostic biomarkers: 
knowing the biomarker concentration in the blood or urine in a patient’s sample makes it possible to 
define a cut-off value (107).  
Figure 8. Presentation of the working of Progenesis for MSE data. Data are aligned and peak detection occurs. For peptide 
identification, an input file is created for the Ion Accounting (IA) algorithm by Apex 3D, lock-mass correction and Peptide 
3D. Subsequently, database searching was performed using the IA algorithm. The output file was subsequently matched to 
the MS precursors identified in Progenesis. Quantitation can also be determined out of the peak detection made by Progenesis 
(2.2.1.3). 
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Several technologies are available in relative and absolute quantification. These are described into detail 
below. 
2.2.1 Relative quantification 
Relative quantification technologies can be divided into three groups: metabolic labeling, chemical 
labeling and label-free quantification. As can be observed in Figure 9, the point in the protocol where 
samples are joined and where consequently technical variation can no longer accumulate differs 
significantly between approaches. Samples are combined the earliest with metabolic labeling, followed 
by chemical labeling and no combination of the samples takes place with label-free quantification. The 
latter approach thus is most prone to technical variability and preparative steps need to be minimized 
herein. 
 
 
 
 
 
Figure 9. Presentation of the different technologies for relative quantification. This scheme shows the different stages of 
an experiment (starting from cell culture to mass spectrometry analysis). The 2 boxes (white and grey) represents the two 
samples, while the horizontal black line denotes the stage in which samples are combined. (Figure adapted from (108)) 
2.2.1.1 Metabolic labeling 
In metabolic labeling, the proteome is labeled during cell culture or in vivo by means of a stable-isotope 
labeled medium. An unlabeled culture/organism is used as a reference. This stable-isotope labeled 
medium induces a mass shift of the precursor peptide ion, making relative quantification possible (72). 
Stable Isotopic Labeling by Amino Acids in Mammals (SILAM) labels organisms in vivo (109). This is 
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possible by feeding the organisms with a 13C or 15N-enriched diet (in the form of spirulina) or by using 
13C6 L-lysine (109, 110).  
The technology that labels cell cultures is called Stable Isotopic Labeling by Amino Acids in Cell culture 
(SILAC) and is developed by the group of M. Mann in 2002 (Figure 10A) (111). SILAC makes use of 
one or two labeled amino acids to label the proteome. These amino acids have to be essential, because 
otherwise a mix of labeled and non-labeled amino acids will arise in one sample, resulting in incorrect 
quantification. Essential amino acids in human are histidine, (iso)leucine, lysine, methionine, 
phenylalanine, threonine, tryptophan and valine (112). Arginine is an essential amino acid in several 
cell cultures (113). Of note, amino acids are also present in fetal bovine serum (FBS), used as a nutrient 
source for cells. Hence, this needs to be dialyzed before it can be used in SILAC medium. The first 
SILAC study used deuterated leucine for labeling (111), but it is known that deuterated peptides induce 
a chromatographic shift (other retention time) on a reverse phase column making it more difficult to 
handle the data afterwards (114). In addition, not every peptide contains a leucine, and thus not every 
peptide is quantifiable. For this reason, the use of 13C6 arginine and 13C6 lysine is more popular nowadays 
since trypsin, cleaving C-terminal of those two amino acids, is the most used enzyme for digest (115).  
After a complete incorporation of these amino acids (mostly 5 population doublings), the cells of 2 (or 
to a maximum of 5) samples are combined. After cell lysis and an in-solution digest, samples are ready 
for LC-MS/MS and can be analyzed afterwards.  
Incorporation efficiency and metabolic conversion need to be addressed if SILAC is used for the first 
time. Incorporation efficiency is the time needed to obtain a full incorporation of labels into the proteome 
and is determined by checking the presence of light peptides in the mass spectrum (115). Another issue 
is the possibility of metabolic conversion, such as can be seen when using arginine. This arginine is 
converted to proline and glutamate in some cell types. This results in extra peaks in the mass spectrum, 
resulting in incorrect quantification as is presented in Figure 10B. This metabolic interconversion has 
been reported in HeLa, HEK 293 and hESC (Chapter 5) (115, 116). 
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Disadvantages of SILAC and SILAM are the high cost of the labels and the limited applicability to 
systems grown in a lab environment, excluding e.g. the use of patient samples. But overall these 
techniques are considered to provide the most accurate information. 
 
Figure 10. Stable Isotopic Labeling by Amino Acids in Cell culture (SILAC). (A) Cells are grown in light and heavy 
medium until complete incorporation is obtained (mostly after 5 doublings). After this adaptation phase, the cell populations 
are treated differently, combined, digested and analyzed with tandem mass spectrometry. In the MS spectrum: the precursor 
ion of the light and heavy sample are separated and relative quantification can be performed. (B) Metabolic conversion of 
arginine to proline (P) or glutamate (E) generates an extra peak (heavy + heavy P or E) resulting in incorrect quantitative 
results. (Image adapted from (115, 116))  
SILAC was further optimized for several applications. Dynamic SILAC is used to determine protein 
turnover (117), while pulsed SILAC can be used to quantify protein translation events (118). Super 
SILAC can be used to quantify tissues by using a mix of SILAC-labeled cell lines as internal standard 
(119). 
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Absolute SILAC allows absolute quantification of selected proteins in a complex mixture. SILAC 
labeled proteins are spiked into a cell lysate after purification and concentration determination (by means 
of amino acid analysis or UV absorption at 280 nm) and work as an internal standard (120). 
2.2.1.2 Chemical labeling 
A lot of reagents are available for chemical labeling of peptides. In this introduction, only a limited 
number of these reagents are described: Isotope Coded Affinity Tag (ICAT) (121), isobaric Tag for 
Absolute and Relative Quantification (iTRAQ) (122) and finally 18O labeling (123).  
ICAT is a technique to identify and quantify cysteine containing proteins in a sample. In short, the 
sample is treated with an ICAT tag, consisting of a reactive group which reacts with the sulfhydryl group 
of cysteine, an isotopically coded linker (12C or 13C) and an acid-labile biotin affinity tag. One sample 
is treated with 12C ICAT, another sample with 13C ICAT. Samples are mixed, digested and cysteine 
containing proteins are purified with affinity chromatography (binding with avidin). After LC-MS/MS 
analysis, peptides are quantified in the MS mode. A disadvantage of ICAT is that this technique can 
only be used for cysteine containing proteins (121, 124).  
Other labeling strategies were developed such as iTRAQ and tandem mass tags (TMT) (125). Both 
techniques quantify at the MS/MS level and the labeling strategy is similar in both technologies. For 
this reason, only iTRAQ is discussed into detail (Figure 11). The iTRAQ reagent consists out of an 
isobaric tag (reporter group (mass 114-117 in the 4-plex) and balance group) and an amine specific 
peptide reactive group. Samples are first digested into peptides with trypsin/LysC in an amine-free 
buffer (for example triethylammonium bicarbonate) and subsequently the samples are treated with the 
iTRAQ reagent (114, 115, 116 or 117) which reacts with the free amines in the sample (N-termini and 
lysine on the peptide). After LC-tandem mass spectrometry, relative quantification occurs at the MS/MS 
level (122, 124).  
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Figure 11. Isobaric Tag for Relative and Absolute Quantification (iTRAQ). Presentation of the iTRAQ protocol. The 
iTRAQ tag (consisting out of a reporter group, a balance group and a reactive group) reacts with the free amino groups on the 
peptides. After labeling, the reporter ions in the MS2 can be used for relative quantification. (Image taken from (126, 127)) 
18O labeling is an example of an enzyme-catalyzed labeling technique (126). In here, two 18O atoms are 
incorporated in the C-terminal carboxyl group of a peptide in the presence of a serine protease (for 
example trypsin) and H218O. By treating one of the samples with this method, relative quantification is 
possible at the MS level (123, 126).  
2.2.1.3 Label-free quantification:  
Disadvantages of methods that are based on labeling are amongst others (1) the increased sample 
preparation time, (2) an increased sample complexity, (3) limited sample number that can be analyzed 
at once (SILAC= 5 samples at once), and (4) the high reagents cost (91, 126). Label-free quantitation 
was developed as a solution to provide faster, cleaner and simpler quantification results. Two 
quantitation methods can be distinguished in label-free quantitation: Spectral Counting or Area Under 
the Curve (AUC) measurement (91, 128).  
Spectral counting is based on the fact that abundant peptides are more selected in DDA for 
fragmentation, resulting in more MS/MS spectra. Several approaches are developed: emPAI, absolute 
protein expression (APEX) and normalized spectral abundance factor (NSAF) are some examples. The 
protein abundance index (PAI) quantifies the proteins in the sample by calculating the number of 
observed peptides divided by the number of observable tryptic peptides for each protein within a given 
mass range of the mass spectrometer. emPAI (10PAI -1) is the exponentially modified form of PAI and 
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is directly related to the protein content in the sample. emPAI is considered to give only an indication 
of the protein amount. It does not take into account (1) the length of the protein (a longer protein will 
generate more peptides resulting in more MS/MS fragments) or (2) the probability that the peptide can 
be detected by the mass spectrometer as is done by respectively APEX and NSAF (72, 91). A great 
disadvantage of spectral counting is that saturation effects (i.e. no additional peptides are detected even 
when increasing the protein concentration) are common, resulting in incorrect quantification of proteins 
in a complex sample mixture. In addition, peptides need to be identified before they can be used for 
quantitation and this is dependent of the used database (129).  
AUC measurement on the other hand relatively quantifies the sample by defining the area under the 
curve or signal intensity measurement of the precursor (91). In this thesis, AUC measurement in UDMSE 
mode at the MS1 level was obtained with the Synapt G2Si and analyzed with the commercially available 
Progenesis Q1 Software for Proteomics (Nonlinear Dynamics, Waters). The survey scan (MS1 data) is 
herein used for ion abundance quantitation. The peptide abundance is calculated by summing the 
intensities of all isotopes of the peptide (130) .  
2.2.2 Absolute quantification 
Targeted mass spectrometry under the form of selected reaction monitoring (SRM) and multiple reaction 
monitoring (MRM) is the gold standard for accurate absolute quantification. SRM is performed with a 
triple quadrupole instrument in which the first and the third quadrupole are used as mass filters and the 
second quadrupole as a collision cell. SRM is limited to a hypothesis-driven method. This means that a 
priori knowledge is necessary to perform SRM, so it is mostly used as a validation tool (107).  
Absolute peptide quantification can be performed using peptide standards (e.g. synthetic peptides) or 
protein standards (e.g. absolute SILAC) as internal standard. These standards are spiked in the sample 
before or after the digestion step (107). 
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Studying the molecular biology of stem cells is crucial for a plethora of reasons. Their application in 
toxicology, regenerative medicine, etc. is entirely dependent on the knowledge that is generated in 
fundamental studies. Over the course of three different chapters, the research described in this thesis 
aims at making a valuable contribution to this field by providing a detailed description of several 
experimental considerations in both cell biology and proteomics approaches.  
First, the characterization and culture of hESC is addressed. When hESC culture was introduced at our 
lab, this was a feeder cell culture system (on MEF). Throughout this doctorate, a feeder-free culture was 
optimized because of several advantages described in detail in Chapter 1-Introduction. The main focus 
during the culture optimization is monitoring the pluripotency state of these cells. This technique had to 
meet several requirements. First, it should allow a check-up of the pluripotency of hESC without 
substantial cell-loss. Secondly, it had to be user friendly, permitting everyone to use the technique 
without extensive training. Finally, the technique had to be compatible with the imaging instrument 
present at the lab. The development of this non-invasive technique and its validation by means of flow 
cytometry is described in Chapter 3. 
In the second part of this dissertation, the sample preparation for a bottom-up proteomics experiment in 
human cells was optimized in terms of protein identification and repeatability for label-free quantitation. 
Herein, proteins were analyzed with tandem mass spectrometry (DIA mode) after being prepared 
through (1) cell lysis, (2) protein digestion into peptides by means of trypsin/LysC and (3) peptide 
separation and analysis by LC-MS/MS. This sample preparation protocol was optimized in three cell 
lines and is described in Chapter 4. 
In the last part of the dissertation, SILAC was optimized for hESC analysis. SILAC is a quantitative 
method in which the samples are metabolically labeled during cell culture. The samples can be mixed 
even before cell lysis resulting in minimal technical variability, but the technique can suffer from 
metabolic conversion of the heavy amino acids. More specifically, conversion of arginine was shown to 
be a considerable problem in hESC and had to be reduced in a fully defined and xenofree feeder-free 
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culture, E8 medium in combination with vitronectin, as routinely used in our lab. Several solutions were 
proposed to reduce this arginine conversion in hESC as discussed in Chapter 5.  
Together, the results presented in this dissertation should allow the reader to adapt his hESC cell culture 
system and to be able to monitor the changes thereof, both directly, using the reporter cell line and more 
generally, by quantifying changes in the proteome by either label-free or SILAC-based proteomics 
approaches. 
 
 
 
 
 
   
 49 
 
 
 
 
 
 
CHAPTER 3: MONITORING OF PLURIPOTENCY IN HESC 
Detailed method description for non-invasive monitoring of 
differentiation status of human embryonic stem cells. 
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Abstract 
The (non-)differentiation status of hESC is usually analyzed by determination of key pluripotency 
defining markers (OCT4, NANOG, SOX2, …) by means of RT-qPCR, flow cytometry (FC) and 
immunostaining. Despite proven usefulness of these techniques, their destructive nature makes it 
impossible to follow-up on the same hESC colonies during several days, leading to a loss of information. 
In 2003, an OCT4-eGFP Knock-In hESC line to monitor OCT4-expression was developed and 
commercialized. However, to the best of our knowledge, the use of fluorescence microscopy (FM) for 
monitoring the OCT4-eGFP expression of these cells without sacrificing them has not been described 
in detail to date. Here, we describe such a method in detail, emphasizing both its resolving power and 
complementary nature to FC, as well as the potential pitfalls in standardizing the output of the FM 
measurements. The potential of the method is demonstrated by comparison of hESC cultured in several 
conditions, both feeder-free (vitronectin) and grown on feeder cells (MEF).  
 
 
 
 
 
 
 
 
 
 
 
 
 
  Monitoring of pluripotency in hESC 
 52 
Introduction  
Human embryonic stem cells are characterized by their unlimited proliferation potential (self-renewal) 
and their ability to differentiate into all cell types of the mesoderm, ectoderm and endoderm germ layers 
(pluripotency). These hESC could therefore potentially be useful in the field of regenerative medicine 
(1, 4). The process of differentiation has been extensively explored, but finding ways of keeping hESC 
undifferentiated is equally essential for fundamental clinical research and toxicological screenings 
(131). Commonly used markers for identifying this undifferentiated status include the two key 
pluripotent transcription factors OCT4 & NANOG (14, 132).  
Currently, the differentiation status is routinely measured using immunostaining, real-time PCR and/or 
flow cytometry. Although these techniques have proven their usefulness in analyzing hESC, it is 
necessary to sacrifice cells, which makes it impossible to monitor the same cells during the experiment. 
Here, we evaluate the applicability of a commercially available OCT4-eGFP Knock-In hESC line 
(WiCell Research Institute, Madison, WI) in combination with fluorescence microscopy for non-
invasive examination of (non-)differentiation of hESC. This OCT4-eGFP Knock-In hESC line (= OCT4 
reporter hESC line) was developed in 2003 by means of homologous recombination whereby the 
transcription of enhanced green fluorescent protein (eGFP) is regulated by the promoter region of OCT4 
(61). The pluripotent status of hESC can be verified in this hESC line by means of eGFP detection: a 
decrease in eGFP represents a decrease in OCT4 expression and thus a decrease in pluripotency, 
indicating that the hESC line is differentiating. This hESC line has been used for different purposes, for 
example to analyze cell division and to create induced pluripotent stem cells (133, 134). Non-invasive 
monitoring of OCT4 can be advantageous to e.g. investigate the effect of different culture conditions on 
hESC pluripotency. To our knowledge however, no detailed description of a methodology in which this 
hESC line is used in a non-destructive time-lapse experiment has been published to date. 
A non-destructive and fast way to define the differentiation status of the cells of this hESC line is to 
measure the fluorescence of the hESC colonies by means of fluorescence microscopy (FM). By 
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determination of the densitometric means of a specific colony and the background, the signal to noise 
ratio (s/n ratio) can be compared between different conditions on a daily basis without any loss of cells. 
Flow cytometry (FC) on the other hand allows determining fluorescence at the single-cell level and is 
arguably the gold standard, despite its destructive nature. Our goal was to correlate the measurements 
of both techniques. 
To validate this non-destructive method, hESC were differentiated using 2 µM retinoic acid (RA). Their 
s/n ratio was compared with hESC cultured in medium containing basic fibroblast growth factor (bFGF), 
a well-known growth factor to maintain self-renewal and pluripotency. Subsequently, feeder-free culture 
and feeder cell culture of hESC were analyzed in parallel in order to determine the effect of mouse 
embryonic fibroblasts on our hESC colonies. Fluorescence microscopy measurements added valuable 
information in interpreting FC experiments. More specifically, the use of FM has the additional 
advantage that it allows monitoring of hESC colony morphology and colony homogeneity, which we 
demonstrate to be a considerable source of variance undetected at the single cell level.  
Finally, one application of this method is given where mouse embryonic fibroblast conditioned medium 
(CM) is used to analyze its beneficial impact on hESC growth. 
Material & Methods 
1.1 Materials 
All products were purchased from Life Technologies, Carlsbad, CA, USA unless stated otherwise.  
 
1.2 hESC culture on feeder cells 
Human embryonic stem cells were cultured on feeder layers of inactivated MEF. Mouse embryonic 
fibroblasts were grown to confluence in a T75 culture flask (37 °C, 5 % CO2, 5 % O2) using medium 
composed of DMEM, 10 % FBS, 100 u/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine.  
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Inactivation of MEF occurred by incubation with 10 µg/ml mitomycin C (Sigma-Aldrich, St. Louis, 
MO, USA) during 2.5 hours at 37 °C. The cells were detached from a T75 flask with 0.25 % trypsin-
EDTA and plated on a pre-coated 0.1 % gelatin 6-well plate at a density of 20 000 cells/cm2, and cultured 
as described above. The next day, the WA01 OCT4-eGFP Knock-In hESC (WiCell, Madison, WI, USA) 
were plated on the MEF, and cultured in hESC medium consisting of DMEM/F12 with 20 % KO-SR, 
100 u/ml penicillin, 100 µg/ml streptomycin, 1 % Non-Essential Amino Acids, 2 mM L-glutamine and 
4 ng/ml basic fibroblast growth factor (bFGF). Splitting of the cells was performed every 4-5 days with 
0.5 mM EDTA in dPBS, based on the manufacturer’s protocol for feeder-free splitting.  
Differentiation of hESC was induced by adding 2 µM retinoic acid (RA) and by removing bFGF from 
the hESC medium. 
 
1.3 Feeder-free culture of hESC 
In addition to feeder cell culture, feeder-free conditions were also used to validate the method. For 
feeder-free culture, hESC were plated on a pre-coated vitronectin (VN) plate (coating concentration = 
0.5 µg/cm2) and cultured in Essential 8TM (E8) medium. Splitting was performed every 4-5 days with 
0.5 mM EDTA in dPBS according to the manufacturer’s protocol of culturing hESC in Essential 8TM 
medium. Differentiation of hESC was induced by adding 2 µM retinoic acid (RA) and by removing 
bFGF from the hESC medium used in feeder cell culture. 
 
For the application of the screening methodology, different media were tested. The composition of these 
media is summarized in Table 1. 
 
 
 
 
 
  Monitoring of pluripotency in hESC 
 55 
Table 1 Composition of the different media used for feeder-free culture of hESC  
Components UCM -  UCM + CM -  CM +  
DMEM/F12 + + + + 
1.25 % ITS-A + + + + 
2.5 mM L-glutamine + + + + 
1.25 % NEAA + + + + 
MEF secretome - - + + 
4 ng/ml bFGF - + - + 
 
Insulin-Transferrin-Sodium selenite-Sodium pyruvate (ITS-A) Conditioned Medium (CM) was made 
by adding 15 ml ITS-A Unconditioned Medium (UCM) to an inactivated MEF T75 flask (20 000 
cells/cm2). After culturing for 24 hours, CM was collected and filtered through a 0.22 µm Sterivex GP 
Filter Unit (Millipore, Bedford, MA, USA) for removal of cells and cell debris. 
  
1.4 Fluorescence microscopy & data analysis 
After removal of medium, eGFP expression (ex. 485 nm, em. 515 nm, exposure time 5000 ms) of 6 
colonies/condition was measured daily on an Axiovert 200M inverted fluorescence microscope 
equipped with the Axiovision multichannel fluorescence module and an AxioCam MRM camera (Carl 
Zeiss, München, Germany). Colonies were screened at 10x magnification using a Carl Zeiss Fluar® 
objective (Carl Zeiss) and visualized using Zeiss filter set no. 38 (BP 470/40, FT 495, BP 525/50). For 
larger colonies, different TIFF-images were stitched using Photoshop CS4 (Adobe, San Jose, CA, USA). 
The s/n ratio was determined by dividing the densitometric mean of the colony by the densitometric 
mean of the background.  
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1.5 Flow cytometry 
In general, FC was carried out at the end of each experiment (day 5). In order to obtain single cells, all 
cell cultures were incubated with 0.25 % trypsin-EDTA for 6 minutes. Prior to FC analysis, cells were 
resuspended in PBS + 1 % BSA solution. Flow count beads (Analis SA/NV, Suarlée, Belgium) were 
added to acquire absolute cell counts. The different conditions were analyzed using Beckman Coulter 
Cytomics FC500 and CXP analysis software. A minimum of 10000 events was acquired for each 
condition.  
 
1.6 Celigo S® 
Celigo S® Imaging Cell Cytometer (Brooks, Poway, CA, USA) was used to evaluate the confluency 
(%) during the experiment (from day 0 until day 5). Confluency can be defined as the total coverage of 
the plate. Medium was removed because of auto-fluorescence and PBS was added to the culture to 
prevent dehydration during measurement due to the warmth generated by the system. 
 
1.7 Statistical analysis 
Statistical analysis was performed using Graph Pad Prism 5 (San Diego, CA, USA). Differences were 
evaluated by a Student’s t-test. A p-value < 0.05 was considered statistically significant.  
Results  
1 Method optimization of non-invasive monitoring of differentiation status of hESC  
During this method optimization a detailed comparison was made between monitoring OCT4 expression 
by means of non-invasive fluorescence microscopy (FM) and by “destructive” flow cytometry (FC) as 
gold standard.  
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1.1 Assessing auto-fluorescence  
Auto-fluorescence of cells due to the presence of cellular metabolites such as NADH is a well-known 
issue and must be investigated to avoid misinterpretation of fluorescence data (135). The auto-
fluorescence of MEF was determined by FM and FC, and a non-reporter hESC line (UGENT2, (136)) 
was included as a negative control.  
 
1.1.1 Fluorescence microscopy 
For FM, signal to noise ratio (s/n ratio) is measured by dividing the densitometric mean of the colony 
by the densitometric mean of its background (Figure 1A). For feeder cultures, it is therefore essential to 
determine the background noise that might derive from the auto-fluorescence of the MEF. The MEF 
signal is not detectable near hESC colonies and as such has no impact on the s/n ratio when compared 
to hESC growing in feeder-free culture (on VN) (Figure 1A). 
 
1.1.2 Flow cytometry 
Next, these FM measurements were compared to FC. The fluorescence histogram of the OCT4 reporter 
hESC line (cells detached from a VN plate), from MEF, and of a non-reporter hESC line (UGENT2, 
cells detached from a VN plate), used as a baseline control, is presented in Figure 1B. No auto-
fluorescence was observed in the UGENT2 cell line (fluorescent signal < 100). MEF auto-fluorescence 
however, is clearly present but is 10-fold less compared to the true signal of the OCT4 reporter hESC 
line.  
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Figure 1. Auto-fluorescence of MEF and hESC. (A) Brightfield image (left) and fluorescence image (right) of a OCT4 reporter hESC colony 
cultured on MEF (top) and on VN (bottom) obtained by fluorescence microscopy (FM). No auto-fluorescence of the MEF can be observed. 
The dotted white lines in the right panels illustrate how colonies are manually delineated in all experiments to assess the s/n ratio. (B) Flow 
cytometry results of MEF, OCT4 reporter hESC line (rep. hESC) and a non-reporter UGENT2 stem cell line (UGENT2 hESC). Each histogram 
was scaled to 100% of the peak value. No auto-fluorescence of the UGENT2 cell line is observed. MEF show a weak auto-fluorescent signal, 
but 10 times lower compared to the true signal of the undifferentiated OCT4 reporter hESC line.  
Note that the auto-fluorescence from MEF will have an influence on the fluorescence histogram of 
detached hESC from a plate cultured on MEF. Gating on the FS/SS plot to exclude the MEF from the 
histogram is not possible because no distinction could be made between MEF and hESC in terms of 
FS/SS. However, the relative portion of the inactivated MEF compared to the growing colonies reduces 
over time. As FC is only used at the end of the subsequent experiments, only a small contribution of the 
MEF (<10 %) to the fluorescence histogram is expected for feeder cell experiments.  
Yet, even with decreasing signal during differentiation caution needs to be taken when directly 
comparing the values of FC measurements of hESC grown on MEF and on VN. 
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To assess the resolving power of the FC, complete differentiation of the OCT4 reporter hESC line (by 
means of 2 µM RA, culture on VN) was performed. The fluorescent signal rapidly decreased during the 
first 6 days and completely disappeared after 15 days in culture, falling back to the same level as the 
UGENT2 line, with no detectable auto-fluorescence (data not shown). Further experiments were done 
on 6 day-cultures as these showed adequate reduction in fluorescent signal.  
1.2 Fluorescent signal in OCT4-eGFP Knock-In hESC line on MEF and VN during 
differentiation 
1.2.1 Fluorescence microscopy 
The resolving power of the FM to determine differences in differentiation status was verified as 
described below. The OCT4 reporter hESC line was cultured on feeder cells (MEF) in three different 
media to investigate respectively non-differentiation (hESC medium with 4 ng/ml bFGF), spontaneous 
differentiation (hESC medium without bFGF) and directed differentiation (hESC medium with 2 µM 
RA) and was also compared with feeder-free conditions (human recombinant VN in two different media 
(E8tm medium and hESC medium with 2 µM RA)). Only the conditions with media that contain bFGF 
are assumed to keep the hESC undifferentiated (137). Colony fluorescence (5/6 colonies per condition) 
was assessed daily during 6 days and results were expressed as signal/noise ratios (Figure 2A). The 
experiment was carried out in triplicate. 
 
As expected, addition of 2 µM RA caused a significant decrease in s/n ratio during the time of the 
experiment both on hESC cultured on MEF and VN (Figure 2A). This decrease was linked to a lower 
expression of OCT4, leading to differentiation. Of note, hESC cultured on VN tend to detach during 
forced differentiation by RA, something which can be easily detected when colonies are monitored 
through time by FM based on their coordinates.  
Since 4 ng/ml bFGF is thought to be necessary to keep hESC on MEF undifferentiated, culture of hESC 
in the absence of bFGF would lead to differentiation, but to a slower rate than when differentiation is 
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artificially induced as for example by adding RA. In Figure 2A, the condition without bFGF has a lower 
s/n ratio on day 5 than the condition with bFGF on MEF (s/n ratio of 8.34 ± 2.16 in comparison with s/n 
ratio of 14.58 ± 2.98). This s/n ratio is however higher than when RA was added (s/n ratio of 8.34 ± 
2.16 in comparison with s/n ratio of 2.49).  
Interestingly, an increase in fluorescence in the “undifferentiated” conditions with bFGF both on MEF 
and VN was observed on day 5. This might be explained by (i) an increase in eGFP/cell or by (ii) the 
formation of multilayers (3D growth) resulting in an accumulation of fluorescent signal.  
No significant differences were found in s/n ratio from hESC cultures on MEF and those on VN for both 
the non-differentiating (with bFGF) and the differentiating (with RA) conditions, confirming the low 
impact of auto-fluorescence of the MEF on FM measurements.  
1.2.2 Flow cytometry 
The abovementioned data of FM were compared to FC measurements on the hESC population. Because 
of the destructive nature of this technique, analysis is only performed at the end of the experiment (day 
5) (Figure 2B). Both feeder-free and MEF grown hESC in the presence of bFGF retained the 
undifferentiated status (fluorescent signal > 101). Of note, a small portion of cells in the latter population 
had an eGFP expression between 100 and 101 (Figure 2B asterisk). These cells were most probably MEF, 
as mentioned earlier (auto-fluorescence between 100 and 101 (1.1.2)). The finding that the eGFP/cell 
remained constant in the undifferentiated conditions strongly suggests that the daily increase in 
fluorescence of the undifferentiated conditions as observed by FM is not due to the increase of eGFP/cell 
but rather to a multilayer effect (3D growth) resulting in accumulated fluorescent signal (1.2.1). 
 
In the MEF condition without bFGF, most of the cells were still undifferentiated after a 6-day culture 
(fluorescent signal > 101) but in comparison with the MEF condition with bFGF, a significantly higher 
number of cells with an eGFP expression between 100 and 101 were observed. These results are in line 
with the FM measurements, in which it was shown morphologically that there was a mix of 
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differentiated (low fluorescence; s/n ratio = 2.26) and undifferentiated hESC (high fluorescence, s/n 
ratio = 13.75) on day 5 when bFGF was absent (Figure 2C left).  
 
The conditions with RA showed a clear drop in fluorescence on day 5 which is due to differentiation 
(Figure 2B). This finding is in line with the results obtained by FM (Figure 2A). Remarkably, FM 
images of hESC colonies differentiated with RA revealed the existence of zones (“islands”) with high 
accumulated fluorescence (s/n ratio = ca. 24) (Figure 2C right). This small population of high 
fluorescent “islands” could not be discriminated using flow cytometry as these individual highly 
fluorescent cells were somewhat hidden in the tail of the fluorescence histogram obtained with FC 
(Figure 2B). 
 
In conclusion, when looking only at the s/n ratios measured by FM for pluripotency assessment, it is 
important to take into account that an increase of signal of a whole colony does not correlate with an 
increased eGFP signal per cell and that only a decrease in FM signal can be directly interpreted as an 
ongoing differentiation. A flat signal in FM can be interpreted as a hESC culture with a population of 
differentiating and non-differentiating cells.  
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Figure 2. Fluorescence microscopy (FM) and flow cytometry (FC) results of hESC cultured on MEF and on VN. n= total amount of 
replicates (A) Signal to noise ratio (s/n ratio) measured by fluorescence microscopy of OCT4 reporter hESC cultured on MEF in different 
conditions: hESC medium with 4 ng/ml bFGF (MEF + bFGF, n=3), without bFGF (MEF – bFGF, n=3) and with 2 µM RA (MEF + RA, n=3), 
and on VN in different conditions: E8TM medium (VN + bFGF, n=3) and with 2 µM RA (VN + RA, n=5). In the conditions with RA, no error 
bars are displayed on day 5 because of both colony detachment and because low s/n ratio makes image stitching of the colony infeasible (signal 
colony ≈ signal background). The experiment was carried out in triplicate (n=3) and 6 colonies were monitored in each experiment (B) FC 
results at day 5 of the same conditions as described in A. Each histogram was scaled to 100 % of the peak value. Asteriks indicates MEF 
contamination in the plot of the OCT4 reporter hESC line on MEF with hESC medium + 4 ng/ml bFGF. (C) Fluorescent images of an OCT4 
reporter hESC colony on MEF in hESC medium without bFGF (left image) and with RA (right image). A mix of high fluorescent and low 
fluorescent cells can be observed in the left image. In the right image, “islands” of high OCT4 expression can be observed.  
 
2. Application of non-invasive monitoring of the differentiation status: MEF conditioned 
medium 
A possible application of the above-mentioned non-invasive method is a comparison of different media 
to test their ability to maintain hESC in an undifferentiated state: E8tm medium on VN (positive control) 
versus insulin-transferrin-sodium selenite-sodium pyruvate conditioned medium (CM) versus ITS-A 
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unconditioned medium (UCM). The difference between CM and UCM is that CM contains MEF 
secreted proteins (Method & Materials). ITS-A was used instead of KnockOut Serum Replacement 
(KO-SR), since ITS-A contains no albumin in comparison with KO-SR, a great advantage when 
subsequent mass-spectrometry analysis of the media is envisioned. To our knowledge, this is the first 
time that ITS-A-containing MEF CM without KO-SR was evaluated for its ability to keep hESC 
pluripotent.  
 
On top of validating the impact of MEF secreted proteins, the influence of the addition of bFGF (CM+ 
and UCM+ contain bFGF while absent in CM- and UCM-) was also verified. Besides OCT4 analyses, 
cell number could be determined as well with FC.  
2.1 eGFP expression assessed by fluorescence microscopy 
After a 6-day culture, no significant difference in eGFP expression could surprisingly be observed 
between the positive control (E8TM) and the other conditions (CM+, CM-, UCM+, UCM-) (Figure 3A), 
suggesting that none of the tested supplements significantly downregulated OCT4 expression during 
short term culture. Morphological assessment of the colonies showed a more or less uniform distribution 
of the fluorescence in the colony in all conditions, indicating a comparable multilayer formation if all 
cells have the same OCT4 expression (confirmed with FC).  
 
2.2 eGFP expression assessed by flow cytometry 
Flow cytometry was used to validate the results of FM at the end of the experiment (Figure 3B & C). 
In addition to OCT4 expression at day 5 (by means of x-mean of the green channel, Figure 3B), the 
amount of cells was also counted by using flow count beads as a reference (Figure 3C). Both values are 
expressed as the logarithmically normalized ratio with respect to E8TM (positive control). As seen in 
Figure 3B, a slight decreasing trend (not significant) in OCT4 expression at the single cell level can be 
observed over the different conditions at day 5, confirming FM results. In contrast, the total cell number 
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at the end of the experiments was on average higher in CM compare to UCM with statistical significance 
only found between CM- and UCM- (p-value < 0.05). 
 
2.3 Confluence  
This difference in cell number between CM and UCM was verified by assessing the confluence of 
colonies by use of a Celigo imaging cell cytometer (Figure 3D). Less confluence could be observed in 
the conditions with UCM, confirming the results obtained with FC. 
Figure 3 Influence of different media on hESC pluripotency and cell growth measured by means of FM and FC. The experiment was 
carried out in triplicate or more (n = 3, 4 or 5) and 6 colonies were monitored in each experiment (A) Signal to noise ratio (s/n ratio) after FM 
of OCT4-eGFP Knock-In hESC on VN in combination with different media: E8tm, CM (with and without bFGF) and, UCM (with and without 
bFGF) during 6 days. (B) OCT4 expression by means of x-mean of the abovementioned conditions determined with FC on day 6. Results are 
expressed as the log ratio with respect to E8TM (positive control) for normalized representation. (C) Cell number of the abovementioned 
conditions determined with FC after 6 days. Flow count beads were used to assess absolute count concentration. Results are expressed as the 
log ratio with respect to E8tm (positive control) for normalized representation. *p-value < 0.05 (D) Confluence (%) determined by means of the 
Celigo® cytometer of the same abovementioned conditions during 6 days.  
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2.4 Stress 
We noticed that especially in UCM media repeatability of the experiments was very low. In both FM 
and Celigo however, some stress is induced by removal of the medium before measurement and by the 
lack of a controlled environment in the apparatus used during these experiments (temperature, CO2, O2). 
We hypothesize that this stress caused the lack in repeatability in UCM cultures. No stress was induced 
by analyzing hESC only at the end of the experiment (on day 5) with FC without intermediate FM or 
Celigo measurements (no stress during time of the experiment) and these results were displayed in 
Figure 4A (OCT4 expression) & 4B (cell numbers). Note that media were replaced throughout the time 
course of the experiment and that detached cells were removed each day, as was the case in the earlier 
described experiments.  
 
Importantly, no significant influence of stress on OCT4 expression could be observed. When comparing 
the cell number however, it is clear that the difference in cell number in the different conditions (Figure 
3C) is strongly reduced when hESC are grown without stress. This stress-caused effect can probably be 
avoided by using auto-fluorescence free medium in combination with a controlled environment. 
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Figure 4 Influence of stress induced by measurement on the FM. Flow cytometry results on day 6 of the different media as mentioned in 
Figure 3. No FM measurement was carried out. Results are expressed as the log ratio with respect to E8tm (positive control) for normalized 
representation (A) OCT4 expression by means of x-mean. (B) Cell numbers.  
Discussion 
The goal of this study was to validate an easy and non-destructive method to follow up pluripotency (by 
expression of OCT4) and morphology of hESC. To our knowledge, this is the first detailed description 
of such a method for evaluating the (non-)differentiation status of hESC. It is based on the use of a 
commercially available OCT4-eGFP Knock-In hESC line (WiCell) in combination with a fluorescence 
microscope (FM). Method validation and cell number assessment were accomplished by means of flow 
cytometry (FC) as the gold standard. Therefore, no special live-cell imaging instruments are required 
when implementing this method.  
As a measure of OCT4-expression, colony signal to noise ratio (s/n ratio=densitometric 
meancolony/densitometric meanbackground) and single-cell x-mean of the fluorescence were measured by FM 
and FC, respectively. Using FM, we found a surprising daily increase in s/n ratio of hESC colonies in 
the undifferentiated conditions (+bFGF). When measuring OCT4-expression at single cell level with 
FC, this increase in fluorescence was not observed (same eGFP/cell during the experiment). Therefore, 
increased s/n ratio of whole colonies seen by FM is likely due to 3 dimensional growth (= multilayer 
effect). Although FM can be used for following up the OCT4 expression of hESC colonies, one should 
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keep in mind that converting these images into a single number (s/n ratio) will, by definition, result in a 
loss of information content. Before implementing FM as a non-destructive screening tool, s/n ratio 
values first need to be compared to additional FC measurements to examine the OCT4-expression at 
single cell level.  
FM however, and not FC, can assess changes in colony homogeneity and morphology. This was clearly 
illustrated by “islands” of high fluorescence in RA-differentiated hESC colonies. These “islands” 
expressed high amounts of eGFP and thus OCT4, suggesting the existence of small remaining 
populations of non-differentiated cells after 6 days of RA-induced differentiation. These cells were 
somewhat “buried” in the tail of the FC histogram and are difficulty to be detected by this technique. 
Co-staining with other germ line markers is needed to elucidate the origin of these islands, but this lies 
outside the scope of this study.  
Of note, we tried to define colony homogeneity by following up the standard deviation (SD) of the 
colony during the time of the experiment with FM (colony homogeneity cannot be assessed by FC (only 
single cell analysis)). In theory, a polymorph colony (regions of high and low fluorescent areas) will 
have a higher SD than a uniform colony and the formation of a polymorph colony will lead to an increase 
in SD during the time of the experiment. Different SD calculations were tested, but to our surprise, none 
showed in full the polymorphism of the colony in comparison with the morphological images taken by 
FM (data not shown). However, other analyzing software packages such as ImageJ, can possible be used 
to determine this colony homogeneity.  
Although FC will still be needed to assess information at single-cell level, FM is unique in providing 
daily information about the distribution of OCT4-expression in different colonies in a non-destructive 
way that no other technique can accomplish up to now thereby giving new insights in how cells will 
respond to different stimuli in terms of hESC differentiation. For defining lineage commitment however, 
one must still stain with other markers such as SSEA-1 & GATA4.  
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Once FM measurements have been essayed against FC, our method can be used to e.g. analyze the effect 
of different compounds (small molecules, proteins) on hESC pluripotency, morphology and cell growth. 
This application was tested by observing differences in colony growth in media that were conditioned 
by MEF prior to culture of the hESC. Here, FM was used to monitor the OCT4-eGFP Knock-In hESC 
line in both conditioned and unconditioned medium (UCM) with and without the addition of bFGF. The 
commercially available Essential 8TM medium was used as a positive control (42). Our results indicated 
that all media can retain the hESC in their undifferentiated status during at least 6 days. These findings 
were corroborated by FC measurements at day 6. FC (after FM analysis) and Celigo® however, did 
show a higher cell number at day 6 with hESC grown in CM compared with UCM. This observation 
was not seen by analyzing hESC with FC (no FM analysis) alone. FM analysis and Celigo will induce 
some stress that can probably be avoided by using an incubator system with auto-fluorescent free 
medium (riboflavin is for example a well-known auto-fluorescent substance) (138). More colonies can 
then also be monitored. Indeed, software for automatic measurement of colony fluorescence is already 
under construction by companies like Brooks (CeligoTM system). However, because of the difference in 
half-life between eGFP (half-life ≥ 24 hours) and OCT4 (half-life in mice = 6-8 hours), the fluorescent 
signal follows the OCT4 expression and only the absence of a signal can directly be interpreted as a lack 
of OCT4 in the cell (139-141). 
Of note, a disadvantage of the FM method described here is that for larger colonies, several images need 
to be taken of each colony, which subsequently need to be stitched to visualize the whole colony in a 
single image. In our hands, a lower magnification objective with a lower numerical aperture (NA) (2.5x, 
NA = 0.15 instead of 10x, NA= 0.50) could not be used as this led to lower fluorescent signals of the 
colonies, resulting in unusable s/n ratios. Stitching results in an increased handling time, therefore 
increasing the stress that these cells need to undergo. This is because media needed to be removed to 
avoid auto-fluorescence and the microscope used during these experiments was not equipped with an 
incubation chamber.  
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Conclusion 
We describe in detail a method for the use of fluorescence microscopy (FM) to monitor the (non-) 
differentiation status of human embryonic stem cell (hESC) colonies by using a commercially available 
OCT4-eGFP Knock-In hESC line. We focus on the pitfalls and the benefits of this non-invasive 
screening method by testing it against flow cytometry (FC) as gold standard. FM is capable of following 
the (non-)differentiation status of different colonies during several days, but has the added value of 
observing morphological changes indiscernible by FC. Together with complementary FC data, such as 
cell number and eGFP/cell, this provides an additional dimension in defining the (non-)differentiation 
status of a culture.  
This optimized FM setup can be used to analyze the impact of different media on the (non-) 
differentiation status of the hESC line growing on vitronectin. 
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Abstract 
Sample preparation is the crucial starting point to obtain high quality mass spectrometry data and can 
be divided into two main steps in a bottom up proteomics approach: cell/tissue lysis with or without 
detergents and a(n) (in-solution) digest comprising denaturation, reduction, alkylation/blocking and 
digesting of the proteins. Some important considerations herein are, amongst others, that the reagents 
used for sample preparation can inhibit the digestion enzyme (e.g. 0.1 % (w/v) SDS & 0.5 M guanidine 
HCl), give rise to ion suppression (e.g. PEG), be incompatible with LC-MS/MS (e.g. SDS) or can induce 
additional modifications (e.g. urea). Taken together, all these irreproducible effects are gradually 
becoming a problem when label-free quantitation of the samples is envisioned, such as during the 
increasingly popular UDMSE and SWATH DIA strategies. Here, we describe the detailed validation of 
a reproducible method with sufficient protein yield for sample preparation without any known LC-
MS/MS interfering substances by using 1 % SDC both during cell lysis and in-solution digest.  
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Introduction 
Sample preparation is a critical step towards high quality LC-MS/MS data in proteomics. In addition, 
not only protein identification, but also repeatability between samples becomes very important when 
using label-free strategies such as UDMSE and SWATH DIA (142). When starting from intact cells for 
a proteome analysis, sample preparation most often involves the use of a surfactant to increase the 
protein recovery during cell lysis. Commonly used surfactants for cell lysis, prior to mass spectrometry, 
are TritonX, NP40, SDS, SDC and 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate 
(CHAPS). NP40 and TritonX are non-ionic, non-denaturant surfactants which are chosen for mild cell 
lysis when conservation of native biological structure is required. Sodium dodecyl sulphate and sodium 
deoxycholate, on the other hand, are ionic and denaturant surfactants which can disrupt cell membranes 
and can cause protein denaturation by breaking protein:protein interactions. The zwitterionic and non-
denaturating surfactant CHAPS disrupts protein aggregates and is most often used for 2D gel 
electrophoresis instead of ionic surfactants (74). An important disadvantage of the use of TritonX/NP40 
is that these surfactants are composed of PEG structures (143). Polyethylene glycol, a hydrophobic 
agent, can give rise to ion suppression at the ion source of a mass spectrometer and can be observed in 
the mass spectrum as repeating elements of 44Da (144, 145). For this reason, removal of PEG is required 
resulting in sample loss and (possible) loss of repeatability in the case of label-free quantitative analysis. 
Sodium dodecyl sulphate also has disadvantages: (1) it denatures enzymes such as trypsin leading to 
impaired digestion, (2) it is liquid chromatography incompatible and (3) it causes ion suppression. 
Despite these unwanted side effects, SDS is still used on a regular basis for cell lysis and digestion prior 
to mass spectrometry. Although SDS can be removed after digestion by filter aided sample preparation 
(FASP) as described by Wisniewski et al. and Shevchenko et al. (146, 147), it has been reported that 
this time-consuming method was not able to deplete all SDS, still causing LC-MS problems (147, 148). 
Additionally, reproducible results, which are crucial for label-free quantitation during e.g. HDMSE or 
SWATH are difficult to obtain with the FASP protocol (149). CHAPS equally is MS incompatible (ion 
suppression) and sample clean-up must be performed by for example C18 Zip Tips (150). Finally, SDC 
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also needs to be removed prior to MS, but this can be done by either acid precipitation or two-phase 
solvent extraction after digesting. After these removal steps no LC-MS/MS interference is detected (76, 
151), but at least for two-phase solvent extraction higher variability in peptide and protein identification 
rate has been described in comparison with acid precipitation (152). For this study, a detergent with 
denaturant characteristics (SDC and SDS) was chosen for addition to the cell lysis buffer because one 
can expect that a loss in the native conformation of proteins will lead to more protein identifications in 
a bottom-up proteomics approach.  
After cell lysis, extracted proteins are cleaved into peptides by means of a digesting enzyme, mostly 
trypsin. The addition of a denaturant in this step will keep hydrophobic proteins in solution and denature 
proteins making the cleavage by a digesting enzyme more efficient. The effect of different denaturants 
on protein denaturation and solubilization during digestion has been extensively studied and denaturants 
can be grouped as surfactants (SDS/SDC), chaotropic agents ((thio)urea) and solvents 
(methanol/acetonitrile). Because of the above mentioned problems with SDS, different companies have 
developed MS-compatible surfactants by (1) making them easily removable after digestion by acid 
precipitation before MS analysis (RapigestTM, PPS silent surfactantTM, Protease MaxTM) or (2) by 
assuring that the surfactant did not co-elute with the peptides on a C18 reverse column liquid 
chromatography system (InvitrosolTM) (81, 153-155). Although these surfactants are able to improve the 
digest efficiency of different proteins in comparison to no addition of any denaturant, they are expensive 
compared to SDS or SDC. In 2007, Masuda et al. (156) compared 27 additives, analyzing the effect on 
the solubilization of a membrane fraction derived from both E. coli and HeLa cells prior to digestion. 
SDS gave the best result on protein yield determined with bicinchoninic acid assay, followed by 
RapigestTM and SDC (76, 156). Proc et al. (2010) compared 14 different digesting protocols on their 
efficiency to digest soluble human plasma proteins. In particular, proteins resistant to digestion 
(myoglobin for example) showed a better digestion efficiency with SDS and SDC both in 4, 9 or 16 
hours digesting time compared to urea or combinations of methanol with SDC or trifluoroethanol. They 
were the first to also consider repeatability, which scored best for SDC while the lowest repeatability 
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was observed for urea, which indicates once more the advantage of the use of SDC in UDMSE and 
SWATH above others (79). Finally, Leon et al. (2013) analyzed the digestion efficiency of an in-solution 
digest of 1 % (w/v) Rapigest, 8 M urea or 5 % (w/v) SDC for denaturation and solubilization of proteins 
(denaturants were diluted when trypsin was added to the sample). Sodium deoxycholate in general 
scored best for peptide/protein identifications and protein sequence coverage (152).  
 
Taken together, these reports indicate that the low-cost denaturants, SDS and SDC, seem to be the best 
additives to be used for cell lysate in combination with subsequent digestion. In this report, we focus for 
the first time on the effect of using these reagents throughout the whole protocol, starting from cell lysis 
all the way to the final peptide samples. Hereby, we specifically focus on the repeatability of these 
approaches without substantial loss in protein identification, to assure their compatibility with emerging 
label-free quantitation strategies such as UDMSE and SWATH. A reproducible protocol was hereby 
accomplished by means of using one type of buffer and detergent throughout the whole sample 
preparation protocol (from cell lysis to mass spectrometry analysis).  
Material & Methods 
1.1 Materials 
All products were purchased from Life Technologies (Carlsbad, CA, USA) unless stated otherwise.  
 
1.2 Cell culture of cell lines (RAJI/HeLa/THP1) 
Two suspension cell lines (RAJI/THP1) and one adherent cell line (HeLa) were cultured to confluence 
in a T175 flask (37 °C, 5 % CO2) using medium composed of basal medium supplemented with 10 % 
fetal bovine serum, 100 u/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine. Dulbecco’s 
modified Eagle’s medium (DMEM), DMEM/F12 and Roswell Park Memorial Institute Medium 1640 
were used as basal medium for respectively RAJI, HeLa and THP1 culture.  
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1.3 Cell lysis 
After cell counting with a hemocytometer, four million cells were washed two times with 1x phosphate 
buffered saline and were subsequently lysed in a protein-low bind Eppendorf with 50 mM 
triethylammonium bicarbonate (TeABC, Sigma-Aldrich, St. Louis, MO, USA), supplemented with 100 
units Benzonase Nuclease (Sigma-Aldrich, St. Louis, MO, USA) and 1x Halt Protease and Phosphatase 
Inhibitor Cocktail (PerBio, Erembodegem, Belgium) whether or not in combination with a denaturant 
(4 % (w/v) SDS (MP, Illkirch, France), 1 % (w/v) SDC, 4 %  (w/v) SDC or 10 %  (w/v) SDC (Sigma-
Aldrich, St. Louis, MO, USA)). 
Cells were vortexed and subsequently sonicated (Transsonic 460, Elma) for 10 minutes on ice.  
After centrifugation (10 minutes at 17968xg), the supernatant was used for further analysis. 
 
1.4 Analysis of the protein concentration 
Protein concentration was determined by means of absorbance at 280 nm with a Nanodrop ND-1000 
Spectrophotometer (Thermo Scientific, Rockford, USA). UV measurement was performed since no 
Coomassie results could be obtained because of incompatibility with SDC and SDS. 
Statistical analysis was performed using Graph Pad Prism 5 (San Diego, CA, USA). Differences were 
evaluated by a Student’s t-test. A p-value < 0.05 was considered statistically significant.  
 
1.5 Trypsin digest  
First, compatibility of 1 % (w/v) SDC with other digesting reagents was analyzed. Compatibility of 1 
% (w/v) SDC with a digestion reagent was defined when no white precipitation in a blank sample (50 
or 500 mM TeABC, 1 mM CaCl2 (Sigma-Aldrich), 5 % acetonitrile (Biosolve)) was observed.  Different 
reducing (10 mM DTT vs 5 mM TCEP (Sigma-Aldrich) and blocking/alkylating agents (10 mM MMTS 
vs 20 mM IAM (both from Sigma-Aldrich)) were added to a blank sample and visually checked for 
precipitation. 
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THP1 cell lysate was digested overnight at 37 °C in 500 mM TEABC, 1 % SDC (w/v), 1 mM CaCl2, 5 
% acetonitrile and trypsin/lysC (25:1 protein-enzyme ratio w/w; Promega, Madison, WI, USA) after 
reduction with 10 mM DTT for 60 minutes at 60 °C and blocking with 10 mM MMTS for 10 minutes 
at room temperature.  
1.6 SDC removal by means of acid precipitation or two-phase solvent extraction 
Removal of SDC after a trypsin digest from THP1 cell lysates with 1 % SDC was obtained by acid 
precipitation (pH=2) with 2 % (v/v) trifluoroacetic acid (TFA, Sigma-Aldrich) or by two-phase solvent 
extraction with ethyl acetate (1:1) followed by addition of 2 % (v/v) TFA. After centrifugation, the 
supernatant of the acid precipitation and the aqueous phase (lower phase) in the two-phase system 
contained the peptides and were transferred to another Eppendorf. The precipitates of acid precipitation 
and organic phase (after vacuum evaporation) in the two-phase system were washed with 3x 0.5 %  (v/v) 
TFA. All samples were dried afterwards. Each removal protocol was performed on 5 replicas. 
 
1.7 LC-UDMSE 
After digestion, dried peptides were dissolved in H2O with 0.1 % (v/v) formic acid. Peptides were 
separated on a NanoACQUITY system (Waters Corp., Manchester, UK) with direct injection on a 
NanoACQUITY UPLC® column (1.7 µm BEH130 100 µm x 100 mm C18) at a flow rate of 300 nL/min. 
The column temperature was maintained at 35 °C. The LC-gradient (1 %- 40 % B in 60 min followed 
by 7 min on 85 % B) was obtained by a combination of mobile phase A (H2O + 0.1 % (v/v) formic acid 
+ 3 % (v/v) dimethyl sulfoxide) and mobile phase B (acetonitrile + 0.1 % (v/v) formic acid). All samples 
were analyzed by HDMSE with an in-house optimized collision energy look up table (ultradefinition 
mass spectrometry), (97)) on a Synapt G2Si instrument (Waters Corporation). Therefore, ion-mobility 
dependent collision energy profiles (look up table) in the transfer region are assigned to each individual 
ion mobility separation cycle across the full ion mobility separation range. The ion mobility separation 
wave height was set to 40 V. All analyses were performed in resolution mode with a scan time of 0.8sec. 
Mass accuracy was maintained using a lock spray with glufib (m/z 785.8426, 100 fmol) and leu-
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enkephalin (m/z 556.2771, 200 pg) with a flow rate of 0.5 µl/min. Traveling wave velocity was ramped 
from 1200 m/s to 400 m/s over the full ion mobility separation cycle. Wave heights in the trap and 
transfer were both set to 4 V and wave velocities to 311 m/s and 190 m/s respectively. In low and high 
energy mass spectrometry mode, the collision energy was set to 4 eV in the trap region.  
 
1.8 UDMSE data analysis 
Uniform optimal processing parameters (low energy, high energy, intensity) for UDMSE analysis were 
first determined with Protein Lynx Global Server Treshold Inspector and the data was subsequently 
analyzed with Progenesis 2.0 software (Waters). First, retention time correction between samples had 
to be performed. This was accomplished by the alignment of each sample run to a home-made quality 
control sample run, created by generating an equal mixture of all samples. Subsequently, peak picking 
was performed and data were filtered by charge state (only 2-4+ features were held for analysis). Next, 
normalization was performed to all proteins. After processing, the data were searched against a human 
databank with methylthio (on cysteine) as fixed modification and deamidation (on asparagine and/or 
glutamine) and oxidation (on methionine) as variable modifications. The enzyme specificity was set to 
trypsin, with maximum 1 missed cleavage. False discovery rate was set to 4 %, corresponding to a 
peptide score threshold in our search environment of ± 5.4. Two peptides were required to identify a 
protein. 
 
1.9 Cell lysate analysis: addition of no detergent in comparison with addition of 1 % SDC 
Possible protein/peptide differences between a cell lysate with or without 1 % (w/v) SDC were analyzed 
with LC-UDMSE. In short, the same amount (µL) of both types of THP1 cell lysates (n = 3 per condition 
(1 % (w/v) SDC/no detergent)) was digested as described in 1.5. Each sample was digested in duplo (6 
samples/condition). SDC was removed by acid precipitation as described in 1.6. No pellet wash was 
performed. Peptides were analyzed with LC-UDMSE (1.7). Normalization was performed against all 
proteins. Data analysis was performed with Protein Lynx Global Server. Only common proteins (in 2 or 
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more replicas per condition) were retained to define differences in protein/peptide identifications in both 
conditions.  
Possible differences in abundances between the same proteins and peptides were identified with 
Progenesis 2.0 software. An independent T-test with false discovery rate correction was performed with 
Excel. A Q-value ≤ 0.001 was considered statistically significant. All significant peptides/proteins were 
further analyzed on possible differences in their hydrophobicity (GRAVY) by means of Prot Param 
software (157). 
Results 
1. Cell lysis: the need for a detergent 
Sodium dodecyl sulphate and sodium deoxycholate are two of the most used detergents for cell lysis. 
To validate their added value in terms of yield and repeatability, protein concentration was determined 
in triplicate by a UV measurement assay (280 nm) because colorimetric assays are incompatible with 
detergents. Cell lysis without any detergent, with different concentrations of SDC (1 % (w/v), 4 % (w/v) 
or 10 % (w/v)) and with 4 % (w/v) SDS (based on FASP protocol [6]) were compared after cell lysis in 
2 suspension cell lines (RAJI and THP1) and 1 adherent cell line (HeLa) to coordinately exclude any 
cell line specific effects. Indeed, a significant increase in protein yield in both suspension cell lines 
(THP1, RAJI) for even the lowest concentration of SDC (1 % (w/v)) could be found (Figure 1). 
Compared to 1 % (w/v), addition of 4 % (w/v) or 10 % (w/v) SDC had no added value in increasing the 
protein content. When comparing 1 % SDC with 4 % (w/v) SDS (FASP protocol), one could observe a 
higher protein yield with the use of 1 %  (w/v) SDC in comparison with 4 % (w/v) SDS (p-value < 0.05 
in RAJI, p-value = 0.06 in THP-1 cell lysate) (Figure 1). We concluded that 1 % (w/v) SDC could be 
used as detergent during cell lysis and can be used as a substitute for 4 % (w/v) SDS.  
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Figure 1. Overview optimization cell lysis protocol for RAJI and THP1 cells. One representative of each experiment is shown. UV 
measurement results concerning the effect of SDC and SDS on cell lysis in 2 cell lines. *= significant differences (p-value < 0.05) between no 
detergent and 1 % (w/v) SDC or 1 % (w/v) SDC and 4 % (w/v) SDS.  
 
For the adherent HeLa cell line, 0.25 % trypsin-EDTA was used to detach cells prior to cell lysis. 
However, the addition of 1 % (w/v) SDC gave no significant higher protein yield compared to no 
detergent in this cell line: in multiple experiments the addition of 1 % (w/v) SDC gave rise to equal or 
higher protein yield compared to no detergent. This larger variability in protein yield between 
experiments might be due to differential clustering of cells after detachment from the culture plate which 
can interfere with subsequent protein extraction efficiency. Therefore, direct cell lysis of adherent cells 
without the detachment with 0.25 % trypsin-EDTA was analyzed as well. Interestingly, when cells were 
directly lysed from the washed plate using the different amounts of detergent more reproducible results 
were obtained compared to cell lysis after cell detachment with trypsin. Importantly, protein yield after 
direct cell lysis in 1 % (w/v) SDC was comparable to the ‘standard’ procedure with the 0.25 % trypsin-
EDTA step. 
 
2. Trypsin digest optimization of a cell extract with SDC 
2.1 Compatibility of SDC with chemicals needed for trypsin digest 
During the subsequent steps of the digest, we noticed that precipitation occurs by the addition of some 
reagents. Since SDC precipitates in acid environment it is important to avoid fluctuations in the buffer 
pH. We thus tested the use of TCEP or DTT as reducing agent as well as IAM or MMTS as alkylating 
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reagents in a 50 mM or 500 mM TeABC buffer environment. Sodium deoxycholate precipitation 
occurred when either TCEP or MMTS were added to the blank sample (in 50 mM TeABC, (1 mM 
CaCl2, 5 % (v/v) ACN)). Indeed, these solutions (made in respectively 50 or 500 mM TeABC) have a 
pH of 1 and 4 respectively. However, precipitation could be avoided for all tested reducing and 
alkylating agents when using 500 mM TeABC. Increasing the buffer capacity is thus strongly 
recommended when using SDC for sample preparation.  
 
Of note, using 500 mM TeABC instead of 50 mM TeABC also during cell lysis would greatly increase 
the simplicity of the protocol, resulting in better repeatability. While it is known that osmolarity can 
theoretically have an influence on cell lysis (74), in our hands no significant difference in protein yield 
could be observed in any of the cell lines tested above when using 50 or 500 mM TeABC. In conclusion, 
we recommend the use of 500 mM TeABC in both cell lysis and in-solution digest. 
2.2 SDC removal by means of acid precipitation or two-phase solvent extraction 
After the tryptic digest, the SDC needs to be removed. Using the THP-1 and RAJI cell line, we compared 
the use of acid precipitation (AP) and two-phase solvent extraction (PT) in terms of protein and peptide 
identification efficiency. As can be seen in Figure 2 for the THP-1 cell line, no significant differences 
were detected in the number of proteins (white bars) and peptides (grey bars) between PT and AP. Yet, 
the use of AP produced a more reproducible list of identifications (Supplementary Table 1). Of note, 
when washing the pellet, as suggested by Lin et al. (2010), a small number of proteins/peptides could 
be identified in the pellet wash of both PT and AP. However, no new peptide identifications could be 
detected in these pellet washes and we thus discarded this additional step. 
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Figure 2. SDC removal by means of two-phase solvent extraction (PT) or acid precipitation (AP) for THP1 cell lysates. The need for a 
pellet wash was also taken under consideration (PT pellet and AP pellet). The number of proteins (left axis, white bars) and peptides (right 
axis, grey bars) of the different conditions are presented. Each removal protocol was performed on 5 samples.  
3. Proteomic analysis of cell lysates obtained with or without 1% (w/v) SDC  
In a final analysis, identical amounts of THP1 cell lysates with and without 1 % (w/v) SDC were 
analyzed with HDMSE. Indeed, only small normalization factors were calculated when normalization 
was done against all proteins. Surprisingly, the same number of protein/peptide identifications in both 
conditions was observed (with around 83 % of all identified proteins common between both conditions). 
The identification efficiency (% annotation) was also the same in both conditions. However, in the SDC 
samples, additional unidentified precursor masses (10 %, charge 2-4+) were found at the peptide level.  
By defining the repeatability at the level of feature intensity, we can directly define the technical 
variability that would actually interfere with each of the features present in a sample. Within the different 
replicas (n= 6) in THP1 cell lysates with and without 1 % (w/v) SDC, we therefore calculated the relative 
standard deviation (RSD) of all features (Figure 3). RSD was determined by dividing the standard 
deviation by the mean of the normalized abundances of all replicas/condition for all features separately. 
Out of this data, a frequency plot was made. As can be seen in Figure 3, over 60 % of all features had a 
RSD lower than 20 % in a cell lysate with 1% SDC (grey bars). In contrast, the same RSD was achieved 
for ± 38 % of all features for a cell lysate with no detergent (white bars), indicating a higher repeatability 
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when using 1% (w/v) SDC. While protein identification is a metric that is used in most protocol 
optimizations, the above results illustrate that this actually only shows a limited picture. 
 
Figure 3. Frequency plot considering repeatability. The x-axis represents the relative standard deviation (stdev normalized abundances/mean 
normalized abundances of all replicas/condition x 100) (RSD), the y-axis represents the number of features with this RSD (%). Cell lysates 
with 1 % (w/v) SDC (grey bars) have a higher repeatability in comparison with cell lysates without 1 % (w/v) SDC (no detergent, white bars). 
Discussion  
The majority of studies focusing on optimizing sample preparation use the number of peptide or protein 
identifications as the metric of validation. However, repeatability in sample preparation is of main 
importance when using label-free quantification approaches like HDMSE and SWATH (142). This 
repeatability during sample preparation can only be obtained by using a protocol with a minimum of 
steps. Here, we present a reproducible protocol by using a single buffer and a single detergent throughout 
the entire protocol.  
Tris(hydroxymethyl) aminomethane(TRIS)-HCl, a commonly used buffer, was not the first choice 
because of its reported ion suppression effect, the formation of TRIS-protein adduct ions and its 
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incompatibility with iTRAQ (contains primary amines) (158). TeABC on the other hand, can be 
evaporated by means of vacuum drying and is compatible with iTRAQ analysis. Therefore, TeABC is 
widely used as digesting buffer (pH 8.0). Because of its suitability during in-solution digestion, this 
buffer is also the first choice for cell lysis. In literature, the concentration of TeABC in digest protocols 
is not uniform (concentration between 50 mM and 500 mM). However, we observed precipitation of 
SDC when MMTS and TCEP were added to an in-solution digest containing 50 mM TeABC. Because 
the change in osmolarity does not change cell lysis efficiency, we here argue for the use of 500 mM 
TeABC where no precipitation was observed. Of note, because of the known side reactions with IAM 
(N alkylation and O alkylation), MMTS was used as blocking agent in an in-solution digest (80).  
Next, the use of detergents for cell lysis was validated. A detergent is added to the cell lysis buffer for 
several reasons: (1) solubilization of hydrophobic proteins or membranes or (2) denaturation of proteins 
(breaking protein:protein interactions) (74). Several detergents are available; each having its own 
advantages and disadvantages. In our experiment, SDC and SDS were chosen because of their 
denaturant characteristics, low cost, and promising results based on digest optimizations (76, 146) . 
Different concentrations (1-4-10 % (w/v)) of SDC were compared with 4 % (w/v) SDS (amount used 
during FASP (146)) and no detergent addition. In general, one could observe a reproducible and 
significant higher protein yield with 1 % (w/v) SDC in comparison with no detergent or 4 % (w/v) SDS 
addition. Therefore, SDC can be considered as an alternative for SDS for cell lysis. Next, we have shown 
that higher repeatability between experiments is obtained in adherent cell lines when using direct cell 
lysis instead of first using 0.25 % trypsin-EDTA for detaching the cells. Direct cell lysis is therefore 
recommended for the use in HDMSE and SWATH data-independent acquisition strategies.  
After cell lysis, a trypsin digest is carried out to obtain peptides which can be analyzed in LC-MS/MS. 
As for cell lysis itself, different denaturants can be added to promote the unfolding of proteins. We 
reasoned however, that using the same buffer as for the cell lysis would benefit repeatability. Indeed, 
one must keep in mind that addition of denaturants needs to be done with care: (1) inhibition of trypsin 
activity: 0.1 % (w/v) SDS, 4 M urea and 50 % methanol will lead to a trypsin activity of respectively 
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20, 71 and 31 % (153); (2) incompatibility with LC-MS/MS: SDS gives rise to ion suppression (76) and 
(3) introduction of modifications: high temperature will convert (thio)urea to cyanate resulting in 
carbamylation of lysine, arginine and N termini (146). One percent SDC was chosen as denaturant 
during digestion because of the already reported promising results and its LC-MS/MS compatibility (76, 
151, 152, 156).  
Removal of SDC can be achieved by AP with TFA or by PT by means of 1:1 ethyl acetate with TFA. 
In short, addition of TFA (=AP) leads to SDC precipitation since SDC is insoluble in an acid and 
aqueous environment. During PT, SDC solubilizes in the organic solvent (ethyl acetate) while the 
peptides remain in the aqueous part. Masuda et al. (2007) found that more peptides (±32 %)/proteins 
(±37 %), in particular hydrophobic peptides/proteins, could be identified in an E. coli membrane fraction 
by means of PT compared to AP. They hypothesized that hydrophobic proteins will precipitate with 
SDC when using AP (156). In contrast, Lin et al. (2010) found that more hydrophilic and hydrophobic 
peptides and proteins (±11-12 %) could be identified in rat liver membrane with AP in comparison with 
PT (151). In both articles, no information concerning repeatability is available of the comparison 
between AP and PT (151, 156). Leon et al. (2013) compared the repeatability of PT and AP in a rat liver 
mitochondrial sample: no difference was found between AP and PT at the protein level. In contrast, 
more peptides (11.51 %) were found in PT in comparison with AP resulting in slightly higher protein 
coverage for PT. Higher repeatability was observed in AP (152). Our comparison led to the conclusion 
that no difference between protein or peptide numbers could be observed between AP and PT. A slightly 
higher repeatability appeared to be present with AP. These results are in general a confirmation of the 
results as described in Leon et al. (2013) (152).  
In a final experiment, the impact of the addition of 1 % (w/v) SDC during cell lysis of THP1 cells on 
protein identification and quantification was examined with HDMSE. The same proteins and peptides 
were identified with and without SDC. An increased coverage will undoubtedly be obtained by using a 
longer LC gradient. Higher repeatability was observed in a cell lysate with 1 % (w/v) SDC (lower % 
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RSD) than without SDC, which is a major advantage when using HDMSE and SWATH data-
independent acquisition strategies. 
In conclusion, a sample preparation protocol is presented here with good repeatability and protein yield 
by using the same buffer (500 mM TeABC) and same detergent (1 % (w/v) SDC) starting from cell lysis 
to HDMSE analysis.  
Conclusion  
We have demonstrated that the addition of 1 % (w/v) SDC to a cell lysis buffer resulted in a higher and 
more reproducible protein yield in comparison with no detergent addition in 3 different cell lines, 
making it the most recommend method for HDMSE and SWATH data-independent acquisition 
strategies.  
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Abstract  
We present a fully defined culture system (adapted Essential8TM (E8TM) medium in combination with 
vitronectin) for hESC that can be used for Stable Isotopic Labeling of Amino acids for Cell culture 
(SILAC) purposes. Although a complete incorporation of the labels was observed after 4 days in culture, 
only 7.39 % of all mass spectrometry (MS) precursors displayed a conversion of L-arginine (R) to L-
proline (P) or L-glutamate (E) where the converted peak was less than 10 % of total peak intensities of 
that peptide. To reduce this arginine conversion, E8TM medium was modified by adding (1) L-proline, 
(2) L-ornithine, (3) Nω-hydroxy-nor-L-arginine (Nor-NOHA) acetate or by (4) lowering the arginine 
concentration. Reduction of arginine conversion was best obtained by adding 5 mM L-ornithine, 
followed by 3.5 mM L-proline and by lowering the arginine concentration in the medium to 99.5 µM. 
No major changes in the proteome, pluripotency and cell amount could be observed for these adapted 
Essential8TM media with ornithine and proline. A sudden cell death however, was observed with the use 
of 99.5 µM L-arginine. In conclusion, we suggest using 5 mM L-ornithine to reduce arginine conversion. 
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Introduction 
Stable Isotopic Labeling of Amino acids in Cell culture (SILAC), developed in 2002 by the lab of M. 
Mann, is used to quantify differences in protein abundance between two cell culture conditions by means 
of incorporating stable isotopically labeled or “heavy” amino acid(s) (AA) in a culture (e.g. 13C6 lysine 
in one culture and 12C6 lysine (K) in the other) (111). 13C6 lysine and 13C6 arginine are commonly used 
as heavy AA, in order to quantify every peptide during tandem mass spectrometry since most digests 
are performed with trypsin (115, 159).  
Importantly, incomplete incorporation of heavy AA can lead to skewed light-over-heavy ratios. For 
most cell types, five population doublings are therefore performed for near-complete incorporation (~97 
%) of the heavy AA into the cell proteome (115).  
A second problem is the metabolic conversion of AA during SILAC experiments resulting in incorrect 
light-over-heavy ratios. Metabolic conversion of L-arginine (R) to L-proline (P) and, to lesser extent, L-
glutamate (E) generates (an) extra peak(s) of + 5 Dalton per heavy P or E in the peptide in the MS 
spectrum (159). Especially fast metabolizing cell types like human embryonic stem cells (hESC) suffer 
greatly from this arginine conversion problem (116). Arginine titration as well as a proline titration can 
be used to reduce this arginine conversion (115, 116). In hESC cultures however, lowering the arginine 
concentration can induce differentiation and cell death (116). For this reason, P titration was used as a 
solution to overcome this problem, since the addition of P can theoretically reduce its formation out of 
R (116). However, these reports used undefined culture conditions such as conditioned medium from 
mouse embryonic fibroblasts or an undefined coating like MatrigelTM, making it impossible to determine 
the actual amount of AA present in these media (116, 160, 161). Additionally, the impact of these 
approaches on pluripotency or the rest of the proteome was not assessed. To date, no fully defined 
culture medium for SILAC application is available for hESC, which makes it difficult for laboratories 
to use SILAC directly out of literature for their own applications. Recently, Essential8TM (E8TM) medium 
in combination with vitronectin was developed for culturing hESC in a full xenofree and defined way 
(42).  
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Here, we present the comparison between different arginine conversion reducing strategies on hESC in 
a fully controlled experimental pipeline, coordinately monitoring pluripotency and general proteome 
changes. First, we used a completely defined culture for SILAC by respectively adding different 
concentrations of L-proline, L-ornithine or Nor-NOHA acetate to the E8 culture medium or by lowering 
the L-arginine concentration in this medium. Second, by using an OCT4–eGFP Knock-In hESC line 
(WiCell Research Institute, Madison, WI, USA), cell number and pluripotency could be monitored 
based on OCT4 expression during the time of the experiment by means of flow cytometry (FC) and 
fluorescence microscopy (FM). FM allows non-invasive monitoring of pluripotency and simultaneous 
verification of colony morphology to assess general cell culture health (162). Within the time span of 
the experiment (4 days, complete heavy label incorporation) no differences in OCT4 expression and cell 
number were seen when different concentrations of L-ornithine and L-proline was added to the media. 
However, when lowering the arginine concentration to 99.5 µM, a complete cell loss during the 
experiment was observed in 2 out of 4 experiments. Addition of Nor-NOHA gave no effect on OCT4 
expression, but a significant increase in cell number was observed in comparison with the control (no 
adaptation of the E8 medium). Subsequently, the effect of the different adapted media on the reduction 
of the arginine conversion were analyzed. Herein, 5 mM ornithine, 3.5 mM proline and 99.5 µM arginine 
were the best in reducing the arginine conversion. Finally, these three adapted culture conditions were 
further analyzed concerning their possible effect onto the proteome and were compared to our control 
(no adaptation of the E8 medium).  The analysis of the possible effects onto the proteome was obtained 
by means of a label-free data independent acquisition approach named UDMSE. This technique is similar 
to the MSE parallel fragmentation approach but uses ion mobility as an extra dimension of separation, 
greatly increasing peak capacity and specificity for linking fragments and precursor masses during data 
analysis. This analysis revealed that none of the culture conditions had a major effect within this time 
span of 4 days, but the minor differences found suggest that these effects might well exacerbate over 
longer time periods. In depth analysis of these differences showed that histones and tubulins were 
upregulated in all conditions (in comparison with control), pointing towards a potential impact on 
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mitosis/protein folding and chromatin organization. The addition of L-proline to the cell culture resulted 
in downregulation of pathways related to RNA degradation, heat stress and TGFβ-signaling.  
Material & Methods 
1.1 Materials 
All products were purchased from Life Technologies (Carlsbad, CA, USA) unless stated otherwise. 
  
1.2 Feeder-free culture of hESC 
WA01 OCT4-eGFP Knock-In hESC (Wicell Research Institute, Madison, WI, USA) were plated on a 
pre-coated xenofree vitronectin (VN XF, Primorigen Biosciences, Madison, WI, USA ) 6-well plate 
(coating concentration = 0.5 µg/cm2) and cultured in E8TM medium (37 °C, 5 % CO2 and 5 % O2). E8TM 
medium was made by diluting Essential 8TM 50x supplement 1:50 with “arginine and lysine free” 
DMEM/F12 (Thermo Scientific, Rockford, IL, USA) supplemented with 398 µM L-arginine HCl and 
499 µM L-lysine HCl (both from Sigma-Aldrich, St. Louis, MO, USA). Splitting was performed every 
4-5 days with 0.5 mM ETDA in Dulbecco’s Phosphate Buffered Saline according to the manufacturer’s 
protocol of culturing hESC in E8TM medium. 
 
1.3 SILAC labeling of hESC and culture conditions 
1.3.1 Incorporation of heavy labels into the proteome 
For labeling, E8TM medium was supplemented with 13C6 lysine and 13C6 arginine (both from Thermo 
Scientific) in the same concentrations as the light variant. hESC were harvested after 4, 5 or 6 days in 
culture (3, 4 or 5 population doublings in which a population doubling is defined as a doubling of the 
amount of cells between 2 consecutive days) to examine the time needed for a full incorporation of 
heavy labels. No splitting was performed during the time of the experiment. Media were changed daily. 
The experiment was performed in triplicate. 
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1.3.2 Inhibition of the arginine conversion to P and E 
The composition of the heavy labeled E8TM medium was changed to examine the effect on inhibition of 
arginine conversion. Four different culture conditions were examined: (1) addition of L-proline (3.5-
6.9-10.4-13.9 mM) (Sigma-Aldrich), (2) L-ornithine HCl (0.05-0.5-1-2-5 mM) (Sigma-Aldrich), (3) 
Nor-NOHA acetate (50-100 µM) (Enzo Life Sciences, Farmingdale, NY, USA) and (4) L-arginine 
concentration was decreased from 398 µM (concentration in no adapted E8 medium) to respectively 
199 and 99.5 µM. hESC grown in heavy isotopically labeled E8TM medium were used as a control for 
all SILAC related experiments. 
 
The experiment was done in triplicate for flow cytometry analysis (FC) and a fourth well was used for 
fluorescence microscopy (FM) analysis to assess colony morphology (M&M 1.4). 
 
1.4 OCT4-expression & cell count 
The influence of the different conditions on hESC differentiation was examined by analyzing OCT4-
expression by means of FM and FC. 
Daily monitoring of OCT4-expression was assessed by non-invasive monitoring by means of FM. To 
assess influence of stress, a plate without daily monitoring (FM) but with FC at the end of the experiment 
was investigated to obtain information about OCT4 expression/cell and cell number as described earlier 
(162). 
 
1.5 Cell lysis and digest 
After culture medium removal, cells were detached with 0.25 % trypsin-EDTA (4 min., 37 °C) and 
trypsin was subsequently inactivated with trypsin inhibitor (1:1 w/w) (Sigma-Aldrich). 10 % of the cells 
were transferred to another Eppendorf for flow cytometry analysis. After centrifugation (200xg, 5 min.), 
cells were resuspended in Phosphate Buffered Saline with 1 % (w/v) bovine serum albumin and kept on 
ice until flow cytometry analysis. After centrifugation (200xg, 5 min.) and a wash step with 1x 
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Phosphate Buffered Saline, remaining cells (90 %) were lysed in a protein LoBind Eppendorf containing 
250 µL of 500 mM TeABC (Sigma Aldrich) supplemented with 1x Halt protease & phosphatase 
inhibitors (Thermo Scientific), 125 units benzonase nuclease (Sigma-Aldrich) and 1 % (w/v) SDC 
(Sigma-Aldrich) as a detergent. The Eppendorf was vortexed (30 sec) and subsequently sonicated (10 
min., on ice, Transsonic 460, Elma).  
 
Cell lysates were centrifuged for 10 min at 17968xg and supernatant was further analyzed. Protein 
content of the supernatant was determined by means of a Coomassie Bradford Assay (standard curve 
obtained using bovine serum albumin (0-2000 µg/ml in 10 times diluted cell lysate buffer), Thermo 
Scientific). The cell lysate was digested overnight at 37 °C in 500 mM TeABC, 1 % SDC (w/v), 1 mM 
CaCl2, 5 % acetonitrile (v/v) and trypsin/lysC (25:1 protein:enzyme ratio w/w; Promega, Madison, WI, 
USA), after reduction with 10mM DTT for 60 min at 60 °C and blocking with 10mM MMTS for 10 
min at room temperature. Sodium deoxycholate was subsequently removed by means of acid 
precipitation. Detailed information about this method is described in (163). 
 
1.6 LC-MS/MS 
After vacuum drying in a Centrivap®, peptides were dissolved in H2O with 0.1 % (v/v) formic acid. A 
trapped HPLC system, Dionex Ultimate 3000 (Thermo Scientific), was used to separate the peptides (1 
µg loaded) on an Acclaim PepMap 100® C18 column (75 µm x 25 cm) (Thermo Scientific) at a flow 
rate of 0.3 µL/min. The LC-gradient used for elution was obtained by a combination of mobile phase A 
(H2O + 0.1 % (v/v) formic acid) and mobile phase B (80 % (v/v) acetonitrile + 0.1 % (v/v) formic acid): 
4 % B- 100 % B in 66 min. Data directed acquisition (DDA) on a Triple TOFTM 5600 mass spectrometer 
(Sciex) with a NanoSpray source operating in positive ESI mode was used to assess MS and MS/MS 
data in dynamic accumulation mode. In short, the scan range for MS ranged from m/z 400 to m/z 1250 
with a 250 ms accumulation time. In MS/MS, a scan range from m/z 65 to m/z 2000 with a minimum of 
25 msec accumulation time was used. Rolling collision energy was used in MS/MS. DDA was triggered 
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for m/z with a charge state from 2+ to 4+ which exceeds 50 cps. Former target ions were excluded for 
30 sec. 
 
1.7 Data analysis of DDA data 
1.7.1  Incorporation  
RAW DDA data (wiff files) were loaded into Mascot Distiller (Matrix Science) and processed. A Mascot 
search was subsequently performed with the following parameters: enzyme specificity was set to trypsin 
with maximum 2 missed cleavages. Methylthio (on cysteine) was used as fixed modification and 
deamidation (on asparagine and/or glutamine) and oxidation (on methionine) as variable modifications. 
The precursor tolerance was set to 20 ppm and the MS/MS tolerance to 0.1 Da. Identification was 
considered positive with a p-value < 0.05. After identification, incorporation rate was determined by 
analysis of the L/H ratio. This ratio was determined by defining the light component as a peptide having 
a 12C6 arginine or/and 12C6 lysine and the heavy component as a peptide having a 13C6 arginine or/and 
13C6 lysine. In addition, the conversion of heavy arginine to heavy proline is taken under consideration 
by defining the heavy proline as a satellite modification group. The ratio was accepted by Distiller by 
applying thresholds to 2 measurements: correlation (threshold = 0.9) and fraction (threshold = 0.5).  
For incorporation and conversion calculation, identification is of minor importance and analysis was 
thus extended by using an in-house developed Python script Conversion Finder (CoFi) running at the 
MS precursor mass level. Following the “Quantify then Identify” principle (quantification-driven 
analysis), all MS precursors and not only the identified ones can be analyzed in this way to obtain a 
more complete picture of all precursors which are present in the sample. First, MS precursors exported 
from the Progenesis software appointed the same retention time (tolerance window: ± 1 min) and same 
m/z (tolerance window: ± 0.05 Da) were excluded from the analysis because these features could belong 
to different peptides. Secondly, all m/z were sorted from low to high and MS precursors with no full 
incorporation were isolated by using the formula: m/z + 6.02013*x/charge (x = represents the number 
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of R and K that can be present in the sequence, ranging from 1 to 5) (same retention time (tolerance 
window = ± 0.1 min).  
1.7.2 Quantitative analysis of arginine conversion 
1.7.2.1 AUC measurement 
RAW DDA data were loaded into Progenesis 2.0 Software (Nonlinear Dynamics, Waters). Data 
alignment for retention time correction, peak picking and subsequent normalization against all proteins 
were performed. MS precursors with a charge from 2+ to 4+ were exported to Excel 2010. Because we 
want to analyze arginine conversion on all MS precursors (Quantify then Identify principle), the CoFi 
script was used. The formula in the CoFi script was adapted to m/z + 5.0168*x/charge (x= represents 
the number of P and E that can be present in the sequence, ranging from 1 to 5) because arginine 
conversion is observed in a mass spectrum as a mass shift of 5.0168 Da between two peaks. Arginine 
conversion (%) was calculated from the reported normalized abundances by dividing the sum of the 
normalized abundances of the heavy labeled MS precursors by the normalized abundances of all MS 
precursors (light + heavy) * 100. 
 
1.7.2.2 Quantitative analysis by means of Spectral Counting to confirm AUC measurement 
In a second analysis, RAW data were converted to mgf format by Peak View (Sciex) and searched 
against a human databank using Mascot with the following parameters: enzyme specificity was set to 
trypsin with maximum 2 missed cleavages. Methylthio (on cysteine) was used as fixed modification and 
deamidation (on asparagine and/or glutamine), oxidation (on methionine), Label: 13C(5) P, Label : 
13C(5) E, Label : 13C(6) K, Label : 13C(6) R as variable modifications. The precursor tolerance was 
set to 20 ppm and the MS/MS tolerance to 0.1 Da. Only peptides with a p-value ≤ 0.05 were kept for 
analysis. Arginine conversion (%) of identified peptides was determined by dividing the number of 
MS/MS spectra that were identified with a P or E heavy label by the total number of MS/MS spectra 
identified with a sequence containing P and/or E.  
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1.8 LC-UDMSE as label-free method to analyze the effect of the conditions on the proteome 
After digestion, dried peptides were dissolved in H2O with 0.1 % (v/v) formic acid. Peptides (100 ng 
loaded) were separated on a NanoACQUITY system (Waters Corp., Manchester, UK) with direct 
injection on a NanoACQUITY column (UPLC® 1.7 µm BEH130 100 µm x 100 mm C18) at a flow rate 
of 300 nL/min. The column temperature was maintained at 35 °C. The LC-gradient (1 %- 40 % B in 60 
min followed by 7 min on 85 % B) was obtained by a combination of mobile phase A (H2O + 0.1 % 
(v/v) formic acid + 3 % (v/v) dimethyl sulfoxide) and mobile phase B (acetonitrile + 0.1 % (v/v) formic 
acid). All samples were analyzed by UDMSE with an in-house optimized collision energy look up table 
on a Synapt G2Si instrument (Waters Corporation) (97). This method is described in detail in (163). 
 
1.9 UDMSE data analysis  
Uniform optimal processing parameters (low energy, high energy, intensity) for UDMSE analysis were 
first determined with Protein Lynx Global Server Treshold Inspector and the data was subsequently 
analyzed with Progenesis 2.0 software (Nonlinear Dynamics, Waters). Briefly, an intelligent peak-
modelling algorithm using a wavelet based approach identifies individual precursor peaks retaining all 
relevant quantification and positional information. To combine and compare results from different runs, 
Progenesis QI aligns them to compensate for between-run variation. This results in increased reliability 
and reproducibility of the peptide abundance measurements.  
 
Subsequently, peak picking was performed and data were filtered by charge state (only 2-4+ MS 
precursors were used for analysis). Next, normalization was performed to all proteins. After processing, 
the data were searched against a human databank (SwissProt) with methylthio (on cysteine) as fixed 
modification and deamidation (on asparagine and/or glutamine) and oxidation (on methionine) as 
variable modifications. The enzyme specificity was set to trypsin, with maximum 1 miss cleavage. False 
discovery rate was set to 4 % at the protein level, corresponding to a UDMSE score threshold in our 
search environment of ± 5.4.  
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The measurements are then combined into protein measurements. After removal of any outliers in the 
replicas by means of Multivariate Statistics (Principal Component Analysis, Progenesis software), 
proteins with a minimum of 2 peptides from which at least 1 was unique, were kept for analysis. A p-
value ≤ 0.05 was used to identify proteins which were significantly different between control and 
condition (L-proline/L-arginine or L-ornithine). These proteins were exported to Excel 2010 and were 
further analyzed with Reactome (164, 165).  
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (166) 
via the PRIDE partner repository with the dataset identifier PXD002859. 
Results & Discussion 
1. Incorporation of heavy labels into the proteome 
Before any SILAC analysis can be performed, it is not only recommended to check the incorporation of 
the heavy labels into the proteome, but equally to verify the occurrence of any conversion of the heavy 
label to another amino acid (e.g. L-arginine conversion to L-proline/L-glutamate) (115). While some 
corrective data analysis tools are available, full incorporation without conversion remains the preferred 
point of departure to obtain correct quantitative information. WA01 OCT4-eGFP Knock-In hESC grown 
in E8TM medium were therefore analyzed after 4, 5 or 6 days in culture (3, 4 or 5 population doublings). 
Importantly, no measurable effect on OCT4 expression was observed when using heavy arginine in 
comparison to light arginine. Cell number analysis showed a population doubling rate of 24 hours 
between two consecutive days (data not shown). 
 
Full incorporation was defined when no light counterpart of a peptide could be identified or for which 
the light peptide was only ≤ 5 % of the total peak area (heavy + light) and was first confirmed with 
Mascot Distiller by focusing on the roughly 3000 identified peptides. Of note, some of the completely 
light peptides (2 % in total) were identified as keratins, which are most probably contaminants from 
sample preparation (167). Importantly, identification is not essential for the calculation of incorporation 
and conversion. On balance, only an estimated 16 % of peptide-like precursors gets selected for 
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fragmentation during a conventional DDA run and no more than 58 % of all MSMS spectra gets 
annotated with a false discovery rate of 1 % (96). Additionally any bias that is introduced by sequence-
dependent fragmentation and/or prior knowledge in e.g. selecting search parameters such as variable 
modifications can be avoided. Indeed, using an in-house developed Conversion Finder (CoFi) script, all 
of the 22.000 peptide-like features in the samples could be interrogated for incorporation by looking for 
any mass pair differing 6.02013 Da. Here too, over 97 % of features had no mass pair and was thus 
completely heavy (or entirely light). The same incorporation rate was found at day 4, 5 and 6. Of note, 
for the annotated features ratios from the CoFi script and from Distiller were very comparable (data not 
shown). In conclusion, 3 population doublings (4 days during experiment) is sufficient to obtain a full 
heavy label incorporation into the WA01 OCT4-eGFP Knock-In hESC proteome and this is used in the 
following experiments.  
 
2. Arginine conversion 
With complete incorporation being achieved, arginine conversion was investigated as second possible 
bottleneck when using SILAC. Arginine conversion can now be quantified on all MS precursors without 
prior bias introduced by MS/MS acquisition or identification, as it can be described as an intensity ratio 
of co-eluting pairs of precursors differing m/z + 5.0168*x/charge (x=1-5), wherein x represents the 
number of P and E that can be present in the sequence. Remarkably, only 7.39 % of all MS precursors 
suffered a R to P or E conversion of less than 10 % of the total MS intensity of that peptide, showing 
that arginine conversion in the human embryonic stem cell line is a major issue (Figure 4). In addition, 
around 50 % of all tryptic peptides (between 700-6000 Da) contain at least one proline according to the 
human database of the international protein index (116). For this reason, it is important to inhibit this 
arginine conversion. Analysis of the pathway mediating the conversion from R to P and E (Figure 1) 
indicates that arginine conversion could be inhibited by (1) the addition of L-proline or (2) the addition 
of L-ornithine to the media or (3) by decreasing the arginine concentration (115, 116, 168). Another 
solution is to inhibit arginase, an enzyme that is responsible for the conversion of arginine to ornithine. 
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Arginase can be inhibited by Nor-NOHA (169). Nor-NOHA works as a competitive inhibitor of arginase 
at physiological pH and is around 40 times more potent in inhibiting arginase than the endogenous 
formed Nω-hydroxy-L-arginine in murine macrophages (169, 170). This inhibition of arginase 
theoretically blocks the conversion of L-arginine to L-ornithine. L-ornithine is amongst others a 
precursor of polyamines, needed for cell proliferation in a growing fetus (170). 
 
 Figure 1. Arginine conversion. L-arginine is converted to L-proline and L-glutamate by several intermediate steps. The steps 
in which we intervene for inhibiting the arginine conversion are indicated in the figure as bold red.  
 
2.1 Effect of the different conditions on OCT4 expression and cell number 
Because hESC are known to start differentiating spontaneously upon changes to their culture 
environment, the different conditions (L-proline/L-ornithine/Nor-NOHA acetate/L-arginine) were first 
analyzed for their effect on the differentiation status of the hESC by means of an optimized screening 
method using FM and FC (Figure 2) (162). A low eGFP expression (fluorescence signal <101), 
correlating to a low OCT4 expression, indicates differentiation. When using FM, both colony shape and 
fluorescence signal/surface unit can be measured in a non-invasive manner. This can give important 
additional information on the impact of an experiment on hESC. In such experiments the overall 
fluorescence of the colonies increases with time when no differentiation is induced, as we described 
earlier (Figure 2A) (162). Normal E8TM medium was used as a control. No decrease in OCT4 expression 
or change in colony shape was observed with FM in all tested conditions within the analyzed time period 
of 4 days, needed for complete AA incorporation. For FC, only a small but insignificant loss in eGFP 
signal could be seen (OCT4 expression) at L-proline concentrations above 10.4 mM.  
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When assessing the effect of different treatments on cell number (Figure 3C), addition of 50/100 µM 
Nor-NOHA acetate displayed a positive effect on cell growth (p-value ≤ 0.05). The inhibition of arginase 
would theoretically lead to an increase in arginine. Deamidation of arginine by nitric oxide synthase will 
form nitric oxide (NO). Dependent on the available concentration of NO, NO promotes cell proliferation 
(picomolar and nanomolar) or induces cell arrest (micomolar) (171). The cell proliferation as observed 
in our experiment can therefore be explained if NO is indeed present in low concentrations. Of note, a 
higher cell amount with Nor-NOHA acetate was also reported in neural stem cells (172). When 
decreasing the arginine concentration, complete loss of cells in 1 or more wells was observed in 2 out 
of 4 experiments. No significant effect on cell growth could be observed for the addition of proline and 
ornithine to the media.  
 
In conclusion, a decrease in arginine concentration can lead to complete cell loss and the addition of 
Nor-NOHA acetate can have an influence on cell growth, making these two conditions the least 
favorable options to reduce arginine conversion during a SILAC experiment. 
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Figure 2. Analysis of the different conditions (L-arginine/L-proline/L-ornithine/Nor-NOHA) on OCT4 expression (FM (A) 
and FC (B)) and cell number (C). (A) FM results of the different conditions. The y-axis represents the mean of the fluorescence 
(eGFP signal) of 5 hESC colonies/surface unit (= background) (signal/noise ratios); the x-axis represents the day of the 
experiment. A loss in eGFP expression and thus of signal/noise indicates loss of pluripotency. Because of the 3D growth of 
hESC colonies, an increase in signal/noise is observed during the time of the experiment in undifferentiated colonies as 
described in Scheerlinck et al., 2014 (162). In none of the conditions, significant loss in eGFP was observed. (B) FC results. 
At the last day of the experiment (day 4), a part of the cells were analyzed with flow cytometry in addition to fluorescence 
microscopy analysis to confirm FM results and to obtain information concerning cell amount. The expression of eGFP signal 
in all tested conditions was measured (a minimum of 10 000 events was analyzed). No significant loss of eGFP in any of the 
conditions was observed in comparison with the control, confirming FM results. (C) cell number results (FC, day 4). The 
amount of cells/µL (y-axis) was determined by adding a known number of fluorescent beads as spike-in to the FC samples. 
Only the addition of Nor-NOHA induced a significant increase in cell number. Inconsistent results were observed when arginine 
concentration was decreased. The asterisk depicts a p-value ≤ 0.05 (by unpaired T-test). 
 
2.2 Inhibition of the arginine conversion  
Next, the CoFi script was used to analyze all MS precursors for possible arginine conversion which is 
not possible with Mascot to obtain a more complete picture. All conditions were assessed with DDA for 
their ability to inhibit the arginine conversion. A frequency plot (Figure 3) of all MS precursors 
(identified and non-identified) was made. Arginine conversion was most reduced by 5 mM L-ornithine 
(56.85 % of all MS precursors with ≤10 % arginine conversion), followed by L-proline (40-45 % of all 
MS precursors) and 99.5 µM L-arginine (33.30 % of all MS precursors). Surprisingly, Nor-NOHA 
acetate has no effect on inhibition of the arginine conversion. Although spectral counting of identified 
spectra could be considered less accurate, the reduction in arginine conversion is so intense that the trend 
is reflected even at the level of the identified spectra (Supplementary Data Figure 1). In addition, the 
data presented in Figure 4 were examined in more detail. Herein, the conversion rate of peptides 
containing multiple converted prolines was compared to all identified peptides (Supplementary Data 
Figure 2). In the control, a higher conversion rate for peptides containing multiple P was observed in 
comparison to all peptides. The reduction of the arginine conversion by the adapted culture conditions 
showed the same results: the main reduction was observed with 5 mM ornithine followed by proline and 
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99.5 µM arginine. Of note, 99.5 µM arginine was less able to reduce the arginine conversion rate in 
peptides containing multiple P in their sequence.   
 
Figure 3. Overview of the impact of the different conditions on arginine conversion. The graph represents the relative 
number of MS precursors (y-axis) with x % conversion. The percentage conversion is defined as the intensity ratio of co-eluting 
pairs of precursors (= identified and non-identified peptides) differing m/z + 5*x/charge (x=1-5) wherein x represents the 
number of P and E that can be present in the sequence and was automatically analyzed with the CoFi script. Conversion was 
most inhibited by means of 5 mM ornithine (pink-red bars, 56.85 % of all MS precursors with ≤10% arginine conversion), 
followed by addition of proline (blue bars, 40-45 % of all MS precursors) and 99.5 µM L-arginine (purple bars, 33.30 % of all 
MS precursors). 50 -100 µM Nor-NOHA acetate (green bars) has no effect on inhibition of the arginine conversion as compared 
to the control (yellow). (control= E8 medium in combination with vitronectin) 
 
As a validation of the CoFi script, 5 peptides in all conditions were manually analyzed in Peak View to 
investigate the arginine conversion by means of summed intensities in which one representative peptide 
is shown in Supplementary Data Figure 3. Similar results are obtained with Peak View in comparison 
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with the CoFi script. The same trend was observed in the other 4 peptides (data not shown) and 
confirmed the results as described above. 
 
Of note, L-arginine can theoretically be formed out of L-proline and L-ornithine. Addition of these two 
(light) amino acids to the culture medium can in this way lead to a decrease in incorporation efficiency) 
(116). However, in our experiment, the incorporation efficiency was the same for every condition (~97 
%).  
 
3. After 4 days - only minor changes in the proteome are induced by different treatments  
Based on the findings as described above, 5 mM L-ornithine/3.5 mM L-proline and 99.5 µM L-arginine 
were repeated to analyze the effect of the different treatments on the hESC proteome. HDMSE was used 
as a label-free quantification technique to obtain quantitative data that were further analyzed with 
Reactome to reveal affected pathways.  
 
First, the total set of all identified proteins (2008 proteins, analyzed with Progenesis 2.0) was examined 
with Reactome to define the enrichment of certain pathways simply due to sample preparation. DNA 
replication (FDR: 9.4E-5) was most enriched during extraction and is thus intrinsically enriched in the 
dataset. 
 
Next, significantly different proteins (p-value ≤ 0.05) between control (no change to the medium) and 
condition (addition of either ornithine and proline concentration or decrease in arginine concentration) 
were isolated from Progenesis QI 2.0 as follows. First, outliers in the technical replicate were excluded 
from the analysis by means of PCA (173). Secondly, only proteins identified with a minimum of 2 
peptides of which minimum 1 peptide was unique for quantitation were retained (1096 proteins (54.58 
% of all identified proteins)). Finally, significant different proteins (p-value ≤ 0.05) between control and 
condition were analyzed. Only small differences were observed: 69/82/188 proteins (6.30/7.48/17.15% 
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of all quantifiable proteins (min 2 peptides of which 1 unique)) were significantly different between L-
arginine/L-ornithine/L-proline and control, respectively. In depth analysis of these potentially different 
proteins and pathway(s) was performed with Reactome wherein only those pathways were considered 
in which all proteins (with a minimum of 3) were consistently up- or downregulated. Histones (H2B and 
H4) and tubulins were upregulated in all conditions in comparison with the control. These proteins are 
involved in different pathways such as mitosis, protein folding and chromatin organization. Other 
pathways that were potentially upregulated in comparison with the control were pathways involved with 
mRNA splicing (up in L-proline and L-ornithine) and membrane trafficking (up in L-arginine and L-
ornithine). In addition, the enzyme pyrroline 5-carboxylate reductase 1, responsible for the conversion 
of pyrroline 5-carboxylate to L-proline, was upregulated when L-arginine was reduced in the medium 
(compared to control). Downregulated pathways were only found in the condition with L-proline: 
pathways involved in RNA degradation, cellular response to heat stress and TGFβ receptor complex 
signaling were possibly affected. All proteins (with their respectively normalized abundance) involved 
in all above mentioned pathways can be found in Table 1.  
 
Longer incubation periods are needed to analyze more profound effects on the proteome, but our data 
suggest that only minor changes in the proteome are found at the onset of a SILAC experiment on hESC 
if incorporation took 3 doublings. 
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Table 1. Significantly different proteins (p-value ≤ 0.05) in one condition relative to control. Data were obtained as follows: first, HDMSE 
data were analyzed with Progenesis 2.0 software (Waters). Only the proteins, identified with a minimum of two peptides of which one peptide 
was unique are retained for analysis. Subsequently, only the significantly different proteins (p-value ≤ 0.05) in the conditions (proline, arginine 
or ornithine) relative to control (no change to the  medium) were further analyzed with Reactome to identify potentially up- or downregulated 
pathways. In the table, the different proteins (with their normalized abundance value) belonging to the upregulated or downregulated pathways 
are displayed (in relative to control). Normalized abundances of which the p-value between the condition and control (t-test) was greater than 
0.05 (insignificant) are displayed in bold.  
mitose/protein folding/chromatine organisatie * relative to control   
      
Accession 
number 
Name                   Normalized abundance (mean ± stdev) 
  proline arginine ornithine  control 
P07437 Tubulin beta chain  13.15 ± 0.78 13.80 ± 1.63 14.08 ± 1.04 10.50 ± 1.73 
Q13885 Tubulin beta-2A chain 7.53 ± 0.52 8.65 ± 0.54  7.75 ± 0.35 6.27 ± 0.77 
Q9BVA1 Tubulin beta-2B chain 9.36 ± 0.74 9.43 ± 0.67 9.04 ± 0.79 7.25 ± 0.68 
P04350 Tubulin beta-4A chain 0.40 ± 0.16 0.32 ± 0.25 0.47 ± 0.28 0.24 ± 0.05 
Q9BUF5 Tubulin beta-6 chain 0.44 ± 0.05 0.43 ± 0.06 0.47 ± 0.07 0.38 ± 0.04 
P62805 Histone H4 37.31 ± 2.45 34.33 ± 1.21 33.22 ± 3.44 25.56 ± 4.85 
P33778 Histone H2B type 1-B 7.26 ± 0.82 7.16 ± 0.63 7.79 ± 0.68 5.70 ± 0.74 
P42677 40S ribosomal protein S27 3.61 ± 0.23  2.94 ± 0.36 3.33 ± 0.37 3.06 ± 0.27 
P06493 Cyclin-dependent kinase 1 3.39 ± 0.28 3.16 ± 0.13 3.19 ± 0.31 2.89 ± 0.20 
P30153 Serine/threonine-protein phosphatase 2A 65 kDa regulatory 
subunit A alpha isoform 
1.72 ± 0.16 1.61 ± 0.07 1.70 ± 0.16 1.51 ± 0.09 
P20618 Proteasome subunit beta type-1 1.94 ± 0.44 2.06 ± 0.41 1.93 ± 0.37 1.50 ± 0.26 
Q5BJF6 Outer dense fiber protein 2 0.80 ± 0.19 1.11 ± 0.27 0.94 ± 0.10 1.04 ± 0.12 
P61981 14-3-3 protein gamma 4.05 ± 0.47 5.16 ± 0.39 4.17 ± 1.45 4.91 ± 0.45 
Q9UNM6 26S proteasome non-ATPase regulatory subunit 13 4.22 ± 0.34 4.98 ± 0.41 4.74 ± 0.93 5.19 ± 0.52 
P25786 Proteasome subunit alpha type-1 1.74 ± 0.15 2.02 ± 0.18 1.97 ± 0.43 2.03 ± 0.14 
      
membrane trafficking     
      
Accession 
number 
Name Normalized abundance (mean ± stdev) 
  proline arginine ornithine  control 
Q13885 Tubulin beta-2A chain 7.53 ± 0.52 8.65 ± 0.54  7.75 ± 0.35 6.27 ± 0.77 
Q9BVA1 Tubulin beta-2B chain 9.36 ± 0.74 9.43 ± 0.67 9.04 ± 0.79 7.25 ± 0.68 
P62158 Calmodulin 0.30 ± 0.07 0.40 ± 0.12 0.27 ± 0.17 0.19 ± 0.12 
Q9NP79 Vacuolar protein sorting-associated protein VTA1 homolog 0.70 ± 0.15 1.08 ± 0.11 0.95 ± 0.09 0.79 ± 0.14 
Q8NBS9 Thioredoxin domain-containing protein 5 0.95 ± 0.25 0.95 ± 0.30 1.24 ± 0.09 0.98 ± 0.11 
Q9BUF5 Tubulin beta-6 chain 0.44 ± 0.05 0.43 ± 0.06 0.47 ± 0.07 0.38 ± 0.04 
      
 
pyrroline-5-carboxylate reductase 1 
    
      
Accession 
number 
Name Normalized abundance (mean ± stdev) 
  proline arginine ornithine  control 
P32322 Pyrroline-5-carboxylate reductase 1. mitochondrial 0.24 ± 0.08 0.39 ± 0.12 0.21 ± 0.05 0.16 ± 0.10 
      
RNA splicing      
      
Accession 
number 
Name Normalized abundance (mean ± stdev) 
  proline arginine ornithine  control 
P22626 Heterogeneous nuclear ribonucleoprotein A2/B1 29.74 ± 5.82 27.23 ± 1.36 28.67 ± 4.31 22.09 ± 2.73 
P51991 Heterogeneous nuclear ribonucleoprotein A3 6.17 ± 0.35 4.96 ± 0.48 5.38 ± 1.04 3.81 ± 0.36 
Q13242 Serine/arginine-rich splicing factor 9 0.92 ± 0.07 0.72 ± 0.06 0.93 ± 0.04 0.71 ± 0.07 
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mRNA stability 
      
Accession 
number 
Name Normalized abundance (mean ± stdev) 
  proline arginine ornithine  control 
Q15717 ELAV-like protein 1 2.95 ± 0.21 3.67 ± 0.15 3.23 ± 0.23 3.49 ± 0.45 
Q9UNM6 26S proteasome non-ATPase regulatory subunit 13 4.22 ± 0.34 4.98 ± 0.41 4.74 ± 0.93 5.19 ± 0.52 
P11940 Polyadenylate-binding protein 1 1.00 ± 0.09 1.12 ± 0.12 1.05 ± 0.05 1.14 ± 0.09 
Q92945 Far upstream element-binding protein 2 4.70 ± 0.21 5.45 ± 0.40 4.90 ± 0.64 7.50 ± 1.25 
P11142 Heat shock cognate 71 kDa protein 37.83 ± 2.98 43.59 ± 2.29 42.69 ± 3.37 43.63 ± 1.24 
P25786 Proteasome subunit alpha type-1 1.74 ± 0.15 2.02 ± 0.18 1.97 ± 0.43 2.03 ± 0.14 
      
cellular response to heat stress     
      
Accession 
number 
Name Normalized abundance (mean ± stdev) 
  proline arginine ornithine  control 
P55072 Transitional endoplasmic reticulum ATPase 5.77 ± 0.49 6.14 ± 0.20 5.92 ± 0.07 6.46 ± 0.35 
P11142 Heat shock cognate 71 kDa protein 37.83 ± 2.98 43.59 ± 2.29  42.69 ± 3.37 43.63 ± 1.24 
Q02790 Peptidyl-prolyl cis-trans isomerase FKBP4 2.98 ± 0.10 3.40 ± 0.24 3.10 ± 0.21 3.65 ± 0.38 
      
      
TGF beta receptor complex signaling     
      
Accession 
number 
Name Normalized abundance (mean ± stdev) 
  proline arginine ornithine  control 
P62942 Peptidyl-prolyl cis-trans isomerase FKBP1A 6.02 ± 0.74 6.56 ± 0.57 7.03 ± 1.69 7.73 ± 0.91 
Q16254 Transcription factor E2F4 10.25 ± 0.99 12.27 ± 0.93 10.89 ± 2.35 13.84 ± 1.95 
O95405 Zinc finger FYVE domain-containing protein 9 0.68 ± 0.04 0.94 ± 0.17 0.97 ± 0.17 1.15 ± 0.26 
 
Conclusion 
In conclusion, a fully defined medium is presented to perform SILAC experiments on hESC. With the 
smallest direct effects on the proteome, OCT4 expression and cell number, we suggest to use 5 mM L-
ornithine to reduce arginine conversion in hESC. Thus, this is the first completely defined media for 
SILAC purposes that can directly be implemented.  
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Supplementary data 
 
Figure 1. Spectral counting data of all conditions. These data were calculated as follows: first, spectra were annotated using the Mascot 
search engine (Matrix Science) as described in Experimental Section 1.7. Secondly, the peptides containing a P or/and E in their sequence were 
isolated for further analysis. Finally, the % of MSMS spectra identified with arginine conversion was calculated by dividing the number of 
peptides with an identified heavy P or E label to all peptides containing a P or E in their sequence*100. As can be seen in the Figure, the highest 
reduction in arginine conversion can be obtained by adding 2 mM ornithine or higher or by adding 3.5 mM proline or higher to E8 medium.  
The lowest reduction in arginine conversion can be observed with the addition of Nor-NOHA. These results confirmed the AUC results. 
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Figure 2. Analysis of the arginine conversion on multiple P in the sequence. A. Representation of the arginine conversion of the identified 
peptides. B. Representation of the arginine conversion of peptides containing multiple P in their sequence. As can be observed, more conversion 
of the control (no adaptation of E8 medium) took place in peptides containing more than one P in their sequence in comparison with all 
peptides. The same trend is observed for the reduction of the arginine conversion: 5 mM ornithine is the best in reduction followed by proline 
and 99.5 µM arginine. Of note, 99.5 µM arginine was less able to reduce the conversion rate in peptides with multiple P in comparison with 
all peptides.  
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Figure 3. Comparison of the results obtained by means of Peak View (columns at the back) and CoFi script (columns at the front) on 
the effect of the different conditions for the peptide “SYELPDGQVITIGNER”. The same trend can be observed in both data analysis 
methods: the addition of 5 mM ornithine can reduce the arginine conversion the most, followed by the addition of 3.5 mM proline and the 
decrease in arginine concentration to 99.5 µM arginine to the E8 medium.    
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Because of their unique cell characteristics, hESC are considered to be useful for a plethora of 
applications: (1) to broaden our knowledge considering human development and disease, (2) in cell 
replacement technologies and (3) in toxicity studies, hereby reducing animal based experiments (174). 
When studying hESC, it is important to realize that these cells are exceptionally prone to cellular 
changes following small adaptations to their surroundings. In this dissertation, several tools are provided 
to both monitor hESC cultures in general and to quantify more specific molecular changes at the 
proteome level. Together, these results contribute to the necessary experimental knowledge and “good 
practice” when using hESC in the lab. 
The main concern in hESC culture is the maintenance of pluripotency, self-renewal and karyotype. Good 
cell culture practice requests that these characteristics are routinely examined. Characterization of 
pluripotency is usually done by investigating the expression of transcription factors and/or surface 
markers by means of staining (fluorescence measurement by flow cytometry or fluorescence 
microscopy) or real time PCR (Chapter 1). These screening techniques are labor-intensive and 
expensive. Alternatively, a quick and easy way to check differentiation is by means of studying the 
colony morphology. hESC form round and flat colonies with defined borders of which the cells are 
homogenous in shape as shown in Figure 1A. During differentiation, hESC colonies become patchy 
(Figure 1B) or the individual cells start changing shape (Figure 1C). 
Figure 1 hESC morphology. hESC are kept in culture on inactivated MEF with hESC medium. (A) undifferentiated colony. 
(B,C) differentiated colonies. 
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Studying these morphological changes is however subjective and demands a trained eye. In Chapter 3, 
we describe a more straightforward and objective screening methodology for assessing pluripotency by 
using a commercial OCT4-eGFP Knock-In hESC line (WiCell). Herein, both daily colony morphology 
and expression of OCT4 (by means of eGFP) can be simultaneously monitored for both feeder (on MEF) 
and feeder-free (on vitronectin) culture. This method made it for others possible to follow-up the hESC 
colony not only morphologically, but also the OCT4 expression could be monitored by means of eGFP 
expression. A loss of eGFP expression means a loss in OCT4 expression and thus differentiation. A 
limitation of our method is that only OCT4 expression and no other stem cell-specific markers can be 
followed-up. To our knowledge, no reporter cell line exists in which two stem cell-specific markers can 
be followed-up in hESC. A solution to this problem can be the addition of the analysis of alkaline 
phosphatase. Alkaline phosphatase is an enzyme which is highly expressed in undifferentiated hESC 
(4). Non-invasive detection of alkaline phosphatase is possible using a cell-permeable, non-toxic small 
molecule substrate which becomes fluorescent after dephosphorylation by alkaline phosphatase. This 
substrate diffuses out of the cells during time (23). Several companies (ThermoFisher and Abcam) 
provide an alkaline phosphatase determination kit with a different fluorescent signal (ThermoFisher: 
ex/em 495 nm/519 nm, Abcam: ex/em 360nm/440nm) (175, 176). Therefore, only the Abcam kit can 
be used in our case when combining this kit with the analysis of the expression of OCT 4 in the OCT4-
eGFP Knock-in hESC line (eGFP: ex/em 489 nm/509 nm). Of note, when using this combination for 
the first time, one should first confirm that no spectral overlap took place or if so, compensation was 
performed.  
In addition, other remaining hurdles (in particular the need for an incubation chamber and the auto-
fluorescence of the medium for FM analysis) have to be overcome. At this moment, imaging systems 
with an incubation chamber regulating heat, carbon dioxide or oxygen can be purchased, for example 
the imaging system “cell observer” of Zeiss. In addition, this instrument makes it possible to follow-up 
the cells in a time-lapse experiment. For the latter hurdle, we have analyzed the cells without the use of 
any medium or with the use of PBS. To minimize the effect on the culture however, analysis had to be 
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performed in a minimal amount of time. A solution would be the use of a medium without any auto-
fluorescent compound. For this purpose, ThermoFisher has recently developed “FluoroBrite DMEM” 
which has a 90 % lower auto-fluorescence compared to phenol red-free medium. Importantly, it remains 
to be determined whether it can be used for hESC culture, especially in light of the abovementioned 
“metastable” cellular state of hESC. An integrative pipeline to validate this adapted culture medium is 
presented in this dissertation: (i) The impact of “FluoroBrite DMEM” on pluripotency can be assessed 
by either FC or FM (Chapter 3). (ii) If indeed pluripotency, colony morphology or cell amount is not 
compromised in this medium, a proteome analysis should be performed to define other potential changes 
in the cell. The latter can be attained by either label-free DDA or DIA analysis with minimized technical 
variation (Chapter 4) or by using SILAC (Chapter 5). Of note, in addition to proteomic changes, also 
metabolomic changes can occur when changing culture conditions. For example, naïve stem cells 
catabolize glutamine to maintain a high α-ketoglutarate/succinate ratio. This high ratio promotes 
histone/DNA methylation and maintains pluripotency (177). This analysis show that metabolomics is 
certainly valuable and essential in the analysis of hESC and can be implemented in the future to 
characterize hESC.  
Next to the monitoring of the differentiation status of stem cells, we thus focused in a second part of this 
dissertation on the proteomic analysis of these cells. Under circumstances where a change of hESC 
culture had to be examined, one can analyze the effect on pluripotency and proteome of these cells. The 
field of proteomics has emerged during the last years: mass spectrometry instruments became more 
evolved, obtaining higher speed, sensitivity and resolution resulting in increased peptide and protein 
identifications. In our lab, the ESI-Q-TOF Premier which was used at the beginning of my work was 
replaced by a TripleTOF 5600 (Sciex) and Synapt G2Si (Waters). The growing technical capabilities of 
LC-MS instrumentation shown in Table 1 illustrates the increasing pressure that is put on sample 
preparation (178).  
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Table 1. Overview of mass spectrometers used during this dissertation. Technical information considering data generation during data 
dependent acquisition is displayed. The last row shows data generated with a HeLa cell lysate as described in (178). Improved data quality is 
obtained with Synapt G2Si and TripleTOF 5600 in comparison with the Premier. 
DDA mode Premier (Waters) Synapt G2Si 
(Waters) 
TripleTOF 5600 
(Sciex) 
Mass accuracy 100-250 ppm 1-15 ppm 1-5 ppm 
Resolution in MS 10k FWHM 10-50k FWHM 10-45k FWHM 
Max MSMS/sec 1 30 50 
Average MSMS/min 10-20 100-200 200-300 
MSMS/µg sample in x time 
(178) 
25k/500 µg in 1 month 
 (2-3D LC) 
20k/0.5 µg in 2 hours 30k/1µg in 2 hours 
 
In addition, data-independent acquisition (DIA) is developed, in which theoretically every peptide can 
now be analyzed. Quantitative differences between two or more experiments can be addressed by several 
label-based and label-free approaches. At this moment, the field of proteomics has focused on label-free 
analysis in combination with DIA or DDA. In label-free analysis, samples are mixed at the step of data-
analysis, which makes sample preparation a step of great importance. Regarding DIA or DDA, 
quantitation results based on AUC are improved using DIA in comparison with DDA: (1) every 
precursor peptide ion is observed with DIA and (2) the duty cycle is almost 100 % resulting in more 
accurate and reproducible data (99). Applying these label-free approaches thus increasingly requires a 
thoroughly validated extraction and digestion protocol in which not only identification, but also 
technical repeatability has to be taken into consideration.  
Cell lysis is the first step in the sample preparation protocol. In Chapter 4, we compare different protein 
extraction protocols on different cell lines (two suspension cell lines and one adherent cell line). A 
greater and reproducible protein yield was observed by addition of 1 % SDC in all of these three cell 
cultures in comparison with no detergent. Because its removal by acid-precipitation does not require 
more than one additional step, technical repeatability is not greatly compromised. One very suitable 
application of this detergent is thus in histone extraction by means of acid precipitation on isolated 
                                                 Broader International Context, Relevance and Future Perspectives 
 121 
nuclei, as routinely done for epigenetic studies (179). An acid-insoluble detergent like SDC, improves 
protein recovery while being removed at the mandatory acid precipitation step. Of note, not every cell 
has the same structural characteristics and cell lysis protocols should be adapted for the cell type under 
investigation.  
As for protein extraction, protein digestion should be as reproducible as possible. Herein, the enzymes 
used during in-solution digest need to work in an optimal way. This implies that the protein sequence 
needs to be available for cleavage. This is obtained (1) by unfolding the protein to its primary structure 
(addition of a detergent), (2) by breaking disulphide bridges (addition of reductans and alkylans) and (3) 
by using 5 % acetonitrile and 1 mM CaCl2. The addition of acetonitrile allows for higher protein 
accessibility, while Ca2+-ions improves the working of trypsin (180). Again, SDC is the detergent of 
choice because peptides remain soluble in 2 % TFA, while SDC precipitates. 
Similarly, increased enzyme specificity can be considered to increase technical repeatability as reported 
in literature. The combination of trypsin with lysC makes it possible to cleave peptides on the C-terminal 
side of lysine even when lysine is followed by proline. Of note, when a quantitative workflow using 
chemical labeling is preferable, such as in iTRAQ, it is important to realize that using e.g. TeABC as 
buffer avoids that primary amines in the buffer (as for example with TRIS) would interfere with label 
efficiency and that TeABC easily is removed by vacuum drying (180). We thus suggest here to use 
TeABC as a standard buffer system compatible with all conventional workflows in quantitative 
proteomics. 
In summary, we here described a detailed protocol that can be used from cell lysis to peptide analysis 
wherein we thoroughly validate (1) repeatability, (2) peptide identification and (3) MS compatibility. In 
addition, the possibility of peptide loss during SDC removal is analyzed. To our knowledge, this is the 
first sample preparation protocol from cell lysis to LC-MS/MS which uses a minimal number of steps 
and in which repeatability and identification is addressed. This protocol can easily be implemented in 
                                                 Broader International Context, Relevance and Future Perspectives 
 122 
other laboratories and can be used for label and label-based purposes. In addition, it makes no use of 
expensive detergents such as Rapigest or ProteaseMax.  
Despite the optimized extraction and digestion protocol presented in this dissertation, the intrinsically 
accumulating technical variability in the label-free approaches will always leave room for the parallel 
existence of metabolic labeling strategies. Most accurate information can be provided by using stable-
isotopic labeling by amino acids (SILAC), in which samples are already mixed before cell lysis. Before 
using SILAC, one should investigate if full incorporation of the heavy label took place and if no in vitro 
conversion of the heavy amino acid is visible. Although the technique was developed using deuterated 
leucine, it was quickly evident that this heavy label was not the ideal choice because (1) not every 
peptide contains leucine and (2) the use of a deuterated label evokes a shift in retention time making 
data analysis afterwards more difficult (115). The use of 13C6 arginine and 3C6 lysine in combination 
with trypsin as digestive enzyme made it possible to theoretically quantify each peptide. However, the 
use of arginine as heavy label has shown an in vitro conversion to proline, resulting in quantification 
errors. This was also the case in our hESC culture system. Of note, the culture system used at our lab is 
E8 medium in combination with vitronectin as coating, which is ideal for proteomic approaches: no co-
culture of other cells and a fully defined medium which made it possible to discriminate between 
proteins derived from hESC and from medium. The arginine conversion in our culture system could be 
inhibited by several solutions in which the addition of 5 mM ornithine to the medium resulted in the 
largest reduced conversion without major effects onto the proteome (Chapter 5). Of note, hESC in their 
adapted media were first monitored for their effect on pluripotency as described in Chapter 3 and the 
sample preparation for proteomics was performed using the protocol as described in Chapter 4, showing 
the usefulness of both methods. This adapted culture system can now be used for SILAC experiments 
with hESC. The advantage of our method over other described methods is that our method uses a fully 
defined culture system avoiding lot variability, as would be the case when using for example MEF CM 
as medium or Matrigel as coating. Undefined culture systems can in particular lead to inconsistent results 
between different laboratories. In addition, the use of ornithine is a new way to reduce conversion in 
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cell lines and can consequently be tested in other cell lines as well which have also a problem in arginine 
conversion such as HeLa or HEK cells.  
In conclusion, in this dissertation we have described a workflow for respectively the cellular monitoring 
of human embryonic stem cells and for the quantitative and qualitative analysis of the proteome either 
by means of a label-based (SILAC) or label-free approach. Besides these issues in cell culture and 
sample preparation, future efforts will need to address (1) LC-MS data acquisition and (2) data analysis 
software tools, especially when considering the relatively new DIA approach. With the same amount of 
wet lab work, now come considerably larger datasets. Increasingly, this is skewing the field of 
proteomics to the data analysis part of the workflow, where bioinformaticians have by now become an 
essential link in the chain. Yet, the main pitfall of this evolution is that it might lead to negligence during 
the sample preparation. This dissertation emphasizes the importance of continuously keeping a careful 
watch on the whole experimental pipeline, from biological sample to data analysis.
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hESC are an important model system and display great promise for applications in toxicology and 
medicine. However, a hallmark of these cells is their “meta-stable state” in culture, meaning that even 
small disruptions to the culture system can easily result in the loss of pluripotency and “spontaneous” 
differentiation. In this work, a non-invasive method for monitoring hESC pluripotency is presented 
which is easy to use. While proven to be essential, OCT4 monitoring alone can never match a complete 
proteomics assessment of the culture system. Thus, either as an additional screening or to more 
specifically define changes following e.g. toxicological treatments, a proteomic analysis can be used to 
address potential proteomic alterations.  
Quantitative information can be obtained either with label-free quantitation or with label-based 
approaches (SILAC, iTRAQ). Label-based quantitation is prone to less technical variation, because 
samples are mixed in an earlier stage of the experimental workflow. In hESC however, this technique 
can not directly be applied to the culture used in our lab, because of the observed metabolic conversion 
of the heavy labeled arginine to proline. Indeed, this conversion could be reduced, hereby making 
SILAC applicable to hESC. Because of the use of a fully defined and xenofree hESC culture, others can 
use this protocol directly for their own purposes. When SILAC cannot be used, label-free quantitation 
is increasingly becoming the method of choice, because of its straightforward workflow. However, to 
minimize technical variation, a sample preparation protocol was developed which is reproducible and 
provides sufficient peptide identification.  
In the future, label-free quantitation with DIA will increasingly become the method of choice because 
of its cheapness and the possibility to analyze a lot of samples at once. With a well-monitored cell culture 
and a reproducible extraction method, it might even compete with SILAC in terms of accurate 
quantitation when defining biological changes. In conclusion, however, thoroughly optimizing and 
validating an experimental protocol remains the central pillar of good practice. 
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The cooperation with Ghent Fertility and Stem cell Team (G-Fast) (Ghent University Hospital) made it 
possible to set up a human Embryonic Stem Cell (hESC) culture at our lab. At the start of this 
dissertation, hESC were kept in culture on a feeder layer of mouse embryonal fibroblasts. However, this 
type of culture results in a more difficult analysis of hESC and influences the study of hESC 
considerably. For this reason, a feeder-free culture was used, more specifically the culture of hESC in 
Essential 8 medium in combination with vitronectin. This culture is completely defined and xenofree. 
The hESC culture was at that moment only morphologically examined in order to detect the presence of 
differentiated cells. This method is however very subjective, so the use of a commercially available 
reporter hESC line was validated in which the expression of eGFP is under the control of the 
pluripotency gene OCT4 (Chapter 3). The use of a fluorescence microscope made it possible to examine 
hESC objectively at that moment. A lower expression of eGFP is related to a lower expression of OCT4. 
Additional advantages of our method in comparison with flow cytometry, the gold standard in most 
screenings, are that differences in OCT4 expression in the colony itself can be shown and that the cells 
can be kept in culture after screening. The main obstacle in this approach is the auto-fluorescence of the 
medium. For this reason, no medium was used during the analysis. This led however to cellular stress. 
hESC are very sensitive to changes in their environment. Even if no effect on pluripotency can be 
observed by means of the abovementioned method, it remains important to screen other changes for 
example at the protein level. The sequel of this dissertation was therefore characterized by the 
optimization of a workflow for the proteomic analysis of hESC. 
Metabolic labeling strategy or SILAC is one way to obtain both quantitative and qualitative information 
about the proteome. In this method, isotopically labeled amino acids (such as arginine and lysine) are 
added to the culture medium and are built into the proteome. Before this technique can be used for a 
comparative study in a certain cell culture, one should examine if (1) a complete incorporation of heavy 
labels took place and (2) no in vitro conversion was observed of arginine to proline. Several possibilities 
are described in literature to inhibit this conversion: addition of proline or lowering the amount of 
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arginine in the medium. In this dissertation, both solutions were analyzed, but also the addition of 
respectively ornithine or Nor-NOHA to the medium was examined as described in Chapter 5. By using 
the optimized screening methodology with the OCT4 reporter hESC, as described in Chapter 3, the 
different “adapted” media were examined in terms of pluripotency, colony morphology and cell amount. 
Only a positive effect on the cell growth by the addition of 50 µM Nor-NOHA and a suddenly cell death 
using low concentrations of arginine were observed. The other media were usable for hESC culture. 
Further examination showed that addition of 5 mM ornithine and 3.5 mM proline as well decreasing the 
amount of arginine to 99.5 µM in the medium resulted in a significant decrease of the conversion of 
arginine to proline. Finally, these abovementioned culture conditions were further investigated with 
UDMSE to investigate the possible effect onto the proteome. This label-free method makes it possible 
to quantify peptides by means of “Area-Under-the-Curve” quantitation using Progenesis QI (Nonlinear 
Dynamics, Waters). Out of this analysis, one should conclude that no major effect on the proteome in 
comparison with the control (E8TM medium without any addition) could be observed in this short time 
frame. 
To make this label-free analysis possible, the existing sample preparation protocol had to be optimized 
for protein extraction on human cells. Repeatability during sample preparation is in this label-free 
technique of great importance to obtain accurate quantitative information. In contrast to SILAC, samples 
are only analyzed together at the step of data-analysis.  
This protocol, as described in Chapter 4, is optimized from cell lysis up to “in-solution” digest and 
makes use of one detergent, 1 % (w/v) SDC, and one buffer, 500 mM TeABC. 1 % (w/v) SDC was 
chosen because of (1) the reported efficiency to denature proteins (similar as SDS), (2) the cost (much 
cheaper in comparison with for example RapigestTM) and (3) the possibility to remove SDC by means 
of acid precipitation in which peptides remain in solution. 
This dissertation describes and validates in detail the several technical considerations that have to be 
addressed for the study of the hESC proteome. Cells need to be monitored in detail in terms of 
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pluripotency and colony morphology, certainly if something needs to be changed to the culture 
conditions, as for example was the case in techniques using metabolic labeling like SILAC. However, 
because data-independent data acquisition will become more and more important, strong validation of 
the protein extraction and digestion in terms of repeatability is needed, certainly if these label-free 
approaches will compete with label-based approaches.  
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De samenwerking met het Ghent Fertility and Stem cell Team (G-FaST) (Universitair Ziekenhuis Gent) 
maakte het mogelijk om een humane Embryonale Stam Cel (hESC) cultuur op te zetten in ons labo. Bij 
aanvang van dit doctoraat werden deze cellen op een feeder layer van muis embryonale fibroblasten in 
cultuur gehouden, maar deze vorm van cultuur bemoeilijkt en beïnvloedt de studie van hESC aanzienlijk 
(Hoofdstuk 1). Om deze reden werd er gekozen voor een feeder-vrije cultuur genaamd Essential 8 
medium in combinatie met vitronectine. Deze cultuur is volledig gedefinieerd en xenovrij.   
De hESC cultuur werd op dat moment enkel morfologisch beoordeeld op de aanwezigheid van 
differentiërende cellen. Doordat deze methode echter te subjectief is, werd het gebruik van een 
commerciële reporter hESC lijn gevalideerd waarbij de expressie van eGFP onder controle staat van het 
pluripotentie kenmerkend gen OCT4 (Hoofdstuk 3). Door gebruik te maken van een 
fluorescentiemicroscoop is het nu mogelijk om hESC objectief te beoordelen. Een lagere eGFP 
expressie is immers gerelateerd aan een lagere expressie van OCT4. Bijkomende voordelen van onze 
methode ten opzichte van flow cytometrie, de gouden standaard in de meeste screenings, zijn dat 
verschillen in OCT4 expressie in de kolonie zelf aangetoond kunnen worden en dat de cellen na 
screening verder in cultuur kunnen worden gehouden. Het belangrijkste obstakel in de methode is de 
auto-fluorescentie van het medium. Hierdoor werd er geopteerd om geen medium te gebruiken tijdens 
de analyse zelf. Dit leidde echter tot cellulaire stress.  
hESC zijn zeer gevoelig aan veranderingen in hun omgeving. Zelfs indien er geen effect op de 
pluripotentie zichtbaar is op basis van de bovenvermelde methode, blijft het belangrijk om ook andere 
veranderingen, bijvoorbeeld op gebied van proteïneniveau te screenen. Het vervolg van deze scriptie 
stond dan ook in het teken van de optimalisatie van een workflow voor de proteoomanalyze van hESC. 
“Metabolic labeling” of SILAC is een manier om zowel kwantitatieve als kwalitatieve informatie over 
het proteoom te verkrijgen. In deze methode worden isotopisch zwaar gelabelde aminozuren (zoals 
arginine en lysine) aan het cultuurmedium toegevoegd en ingebouwd in het proteoom. Alvorens een 
dergelijke techniek toe te passen voor een vergelijkende studie in een bepaalde celcultuur, moet 
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nagegaan worden of (1) er volledige incorporatie is van de labels en (2) er een in vitro conversie 
plaatsvindt van arginine naar proline. Verschillende mogelijkheden zijn beschreven in de literatuur om 
deze conversie tegen te gaan: toevoegen van proline of verlagen van de hoeveelheid arginine in het 
medium. In deze thesis werden beide oplossingen uitgetest, alsook de toevoeging van respectievelijk 
ornithine en Nor-NOHA aan het medium zoals beschreven in Hoofdstuk 5. Door het gebruik van de in 
Hoofdstuk 3 geoptimaliseerde screening methodologie met OCT4 reporter hESC, zijn de verschillende 
“aangepaste” media eerst onderzocht op hun effect op pluripotentie, kolonie morfologie en cel aantal. 
Naast een mogelijk positief effect op de celgroei bij toevoeging van 50 µM Nor-NOHA en een soms 
plotselinge celdood bij lage concentraties arginine, waren de meeste media bruikbaar voor hESC cultuur.  
Uit verder onderzoek bleek dat de toevoeging van 5 mM ornithine of 3.5 mM proline, alsook de 
verlaging van de concentratie arginine naar 99.5 µM arginine resulteerde in een significante reductie 
van de conversie van arginine in proline. Deze cultuurcondities werden verder onderzocht met UDMSE 
om het potentiële effect op het proteoom te onderzoeken. Deze label-vrije methode laat peptide 
kwantificatie toe aan de hand van “oppervlakte-onder-de-curve” kwantificatie met behulp van 
Progenesis QI (Nonlinear Dynamics, Waters). Hieruit bleek dat er alvast op het onderzochte tijdsverloop 
geen groot effect op het proteoom kon worden gevonden ten opzichte van de controle. 
Om deze label-vrije analyse mogelijk te maken werd het bestaande staalvoorbereidingsprotocol 
geoptimaliseerd voor proteïne extractie op humane cellen. Herhaalbaarheid gedurende 
staalvoorbereiding is in deze label-vrije techniek namelijk van groot belang om tot accurate 
kwantitatieve informatie te komen. Dit is omdat bij deze techniek, in tegenstelling tot SILAC, de stalen 
pas bij data-analyse samen worden geanalyseerd.  
Dit protocol, beschreven in Hoofdstuk 4, is geoptimaliseerd vanaf cellyse tot en met het “in oplossing” 
digest en maakt gebruik van één detergent, met name 1 % (w/v) SDC en één buffer, met name 500 mM 
TeABC. Er werd voor 1 % (w/v) SDC gekozen omwille van (1) de gerapporteerde doeltreffendheid om 
eiwitten te denatureren (gelijkaardig aan SDS), (2) de kostprijs (veel goedkoper dan bijvoorbeeld 
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RapigestTM) en (3) de mogelijkheid om SDC te verwijderen met behulp van zuur precipitatie waarbij 
peptiden in oplossing blijven. 
Deze scriptie beschrijft en valideert in detail de verschillende technische overwegingen die moeten 
worden genomen bij de studie van het proteoom van hESC. De cellen zelf dienen in detail te worden 
gemonitord op vlak van pluripotentie en kolonie-morfologie, zeker als er iets aan de cultuurcondities 
dient te veranderen, zoals het geval bij technieken die berusten op metabole labeling zoals SILAC. Nu 
data-afhankelijke data acquisitie steeds meer aan belang wint, zullen proteïne extractie en digestie zeer 
sterk gevalideerd moeten worden op vlak van herhaalbaarheid, willen deze label-vrije benaderingen de 
intrinsiek minder variabele labelingstechnieken ook naar de kroon stoten.
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